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Abstract 
Introduction: Ulceration is defined as a breakdown of the skin. The treament of ulcers 
can be difficult and both time and cost expensive for the patient and health service. 
Determining what has caused this ulceration and formulating a treatment plan is key. 
There is no one universally accepted test which can accurately predict if a wound will 
heal or what treatment will be successful in healing it. Assessing the peripheral arterial 
system is an important first test to ensure that there is adequate blood perfusion to the 
ulcerated area. This is carried out by performing a test called Toe Brachial Indices 
(TBI’s).  
In 2012 a new test called transcutaneous oximetry (tcpO2) was introduced to the 
vascular laboratory service in a bid to gain extra information on ulcer diagnosis and 
potential healing status. This test examines tissue oxygenation levels at a particular site.  
The purpose of this audit is to determine if tcpO2 provides any additional diagnostic 
information. 
Method: From its introduction in 2012 and for the following three years all results of 
this test and a set of TBI’s were audited. Patients who presented to the vascular service 
with an active foot ucleration had both tests performed. A medical history was taken to 
record the risk factors of peripheral arterial disease.  
Results: There were a total of 247 patients included in the audit which equated to 310 
tests for anaylsis (a number of patients had tests performed on both feet). The age range 
was 32 – 94 years old with a mean age of 67.5 years and a median age of 69 years. Both 
tests were compared. tcpO2 and TBI’S were statistically lower in the smokers in 
comparision to the non smokers. Absolute toe pressures were statistically lower in the 
patients on statins and antihypertensives when compared to those not. Nether of these 
areas are well researched. When all test results were compared 70% of tests had reduced 
TBI results indicating arterial disease. Of this 70%, 39% had a tcpO2 result which was 
below a normal threshold suggestive that spontaneous healing was not likely to occur. 
This group with low TBI’s and low tcpO2 had significant numbers of interventions and 
amputations. More interestingly, the remaining 31% of tests had a tcpO2 test outcome 
which was above the normal threshold suggestive of spontaneous healing. These tests 
required a lower number of interventions and amputations when compared to the tests 
where both results are normal.  
VI 
 
Conclusion: In the setting of peripheral arterial disease the addition of tcpO2 does 
provide additional further diagnostic information that should be taken into 
consideration with a TBI result when treating foot ulceration. In the absence of a TBI 
result it is reasonable to consider a tcpO2 test as an alternative source of diagnostic 
information.  
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Introduction 
 
The human foot is a highly complex structure and any problems it develops can result 
in a deterioration of a patients overall health and hence quality of life. There are various 
diseases, both of the foot and within the body, that lead to foot problems. Ulceration is 
one such problem. Ulceration is where an area of skin, which for whatever reason, has 
broken down and one can see the underlying tissue. Often in many cases the skin heals 
quickly, but unfortunately there are some cases where certain disorders or physiological 
conditions can impede the body’s normal healing process.  
 
One particular metabolic disorder that can prevent a quick healing process is diabetes 
mellitus. Foot ulceration is more common in patients with diabetes because they can 
develop a number of complications which are discussed in chapter 2, section 2.0. These 
complications can lead to minor problems such as small cuts, blisters, bruises etc. going 
undetected which can very quickly become worse and develop into ulceration. The 
complexity of ulceration can be troublesome and doctors look to many disciplines such 
as dermatology, podiatry, endocrinology and vascular diagnostics when treating them 
in the hope of aiding a positive outcome.  
 
Indeed there have been many advances in recent years in terms of both vascular surgery 
techniques and investigative techniques to evaluate lower limb perfusion. These are in 
a bid to help improve perfusion, where it is an obstacle to wound healing. Despite these 
advances there is still no one universally accepted test that can predict wound healing, 
as it is globally accepted that it is dependent on a number of factors both local and 
systemic. General consensus would be that it is unlikely that one test will ever achieve 
100% accuracy. And so, with this in mind the aim of this thesis is to analyse the results 
of a new test introduced into our vascular laboratory service – Transcutaneous 
Oximetry (tcpO2) and to determine if it aids the treatment of patients with active foot 
ulceration and whether it provides any additional or alternative diagnostic information 
which alters the outcome or treatment of foot ulceration? Any additional supports this 
new and non-invasive test can provide to assist in the decision making of treatment 
planning will be quantified. A total of 247 patients were audited from December 2012 
– December 2015. These equated to 310 initial tcpO2 tests with a corresponding TBI 
test. The cost associated with managing and treating a chronic foot ulceration places a 
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significant strain on the health service and one that is going to increase with the 
increasing number of diabetic diagnoses. Cases of diabetes have progressively 
increased worldwide and it has been noted that there has been a two fold increase in the 
numbers of adults with diabetes in recent years. (Danaei et al. 2011). With the 
combination of the excessive costs in treating diabetic foot ulceration, combined with 
the detrimental effects they have on the patients overall health status, it is becoming 
increasingly necessary to develop and implement new methods to predict wound 
healing in this patient cohort.  
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Diabetes Mellitus and lower limb 
arterial disease 
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Background 
2.0  Diabetes Mellitus – what is it? 
Diabetes mellitus is a common but chronic condition which causes significant 
morbidity and mortality if it is not properly diagnosed and managed. It is defined as a 
group of metabolic disorders which are characterised by too much glucose in the blood, 
also called hyperglycaemia. The digestive tract breaks down carbohydrates – sugars 
and starches found in food – into glucose which is a form of sugar that enters the 
bloodstream. The hormone insulin (made in the pancreas) allows the body to then use 
that sugar by helping glucose to enter the cells where it can be absorbed and used for 
energy. The pancreas is located behind the stomach and contains clusters of cells called 
islets. It is the beta cells within these islets that make insulin and are responsible for its 
release into the blood.  
 
Figure 2.1 Islets within the pancreas containing beta cells 
When a person has diabetes, either the pancreas fails to produce enough insulin or the 
body cannot properly use the insulin it has. As a result there is a build-up of glucose in 
the blood causing the cells to be starved of energy.  
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2.0.1 Types of diabetes 
There are two types of diabetes: 
Type 1:  
Type 1 diabetes (previously known as insulin dependent, juvenile or childhood onset) 
is characterised by a lack or deficiency of insulin in the body (World Health 
Organization 1999). Normally the immune system protects the body from infection by 
identifying and destroying bacteria, viruses and other potentially harmful foreign 
substances. Type 1 diabetes occurs due to an autoimmune disease, where the body’s 
immune system attacks and destroys its own cells, which in the case of Type 1 diabetes 
is the insulin producing beta cells in the pancreas. Treatment requires the daily 
administration of insulin (National Institute of Diabetes and Digestive and Kidney 
Diseases 2016). This type of diabetes occurs most frequently in children, with its cause 
not known or preventable to date. Symptoms include excessive urination, thirst, 
constant hunger, weight loss, vision changes and fatigue. Symptom onset may occur 
suddenly.  
Type 2 
Type 2 diabetes (previously known as non-insulin-dependent or adult onset) is the most 
common form of diabetes and is caused by a combination of factors which include 
insulin resistance. This is a condition in which the body’s muscle, fat and liver cells do 
not use insulin effectively. It develops when the body can no longer produce enough 
insulin to compensate for the impaired ability to use insulin (National Institute of 
Diabetes and Digestive and Kidney Diseases 2016). It is largely the result of excess 
body weight and a lack of physical activity. This type is estimated to affect up to 95 
percent of people with the condition. Symptoms may be similar to those of Type 1 
diabetes but are often less marked (Irish Health 2003). This type of diabetes was most 
commonly diagnosed in patients aged 40 or older but it is starting to emerge in the 
population at a younger age (Chronic Conditions Hub 2016). 
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Gestational diabetes is hyperglycaemia with blood glucose values above normal but 
below those diagnostic of diabetes and occurs during pregnancy. Women with 
gestational diabetes are at an increased risk of complications during pregnancy and at 
delivery. This type of diabetes is diagnosed through prenatal screening (Diagnostic 
criteria and classification of hyperglycaemia first detected in pregnancy (World Health 
Organization 2013).  
2.0.2 Consequences of diabetes 
Diabetes places a significant burden of care on the individual, the health care 
professionals and the wider health system (Zimmet et al. 2001). Individuals with it, 
over time, can develop problems with many parts of the body including the heart, the 
blood vessels, the eyes, the kidneys and even the nerves. The following is a list of the 
most common side effects:  
 A combination of reduced blood flow and nerve damage (neuropathy, section 
2.1) in the feet increases the chance of foot ulceration, infection and perhaps 
even lead to eventual amputation (Emerging Risk Factors et al. 2010). 
 Adults with diabetes have a 2-3 fold increased risk of heart attacks and strokes 
(Emerging Risk Factors et al. 2010) 
 Diabetic retinopathy is an important cause of blindness and occurs as a result of 
long term damage to the small blood vessels in the retina (Bourne et al. 2013). 
 Diabetes is among the leading cause of renal failure (National Institute of 
Diabetes and Digestive and Kidney Diseases 2014). 
2.0.3 Prevalence of diabetes  
 
In Ireland, there is no diabetes register or surveillance programme and so estimates of 
prevalence vary. The Institute of Public Health have commissioned a number of reports 
in recent years looking at the prevalence of diabetes in Ireland. “Making Diabetes 
Count” 2005, “Making Diabetes Count 2007” and “Making Chronic Conditions count 
2010 have all shown increasing rises in the number of diagnosed diabetics in the 
Republic of Ireland (Balanda et al. 2010, The Institute of Public Health 2006, The 
Institute of Public Health 2007). Prevalence of the disease has reached all estimated 
targets set out in these reports. It is important to also note, that there are numerous 
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people undiagnosed with the disease. According to the International Diabetes 
Federation (IDF) Diabetes Atlas, sixth edition, there are approx. 70,610 undiagnosed 
cases in Ireland (International Diabetes Federation 2015). 
Diabetes Ireland estimate that during 2011 the number of people, of all age groups, with 
diabetes in Ireland (Type 1 and Type 2 populations combined) reached 191,000 
(Diabetes Ireland 2016). 
Currently Diabetes Ireland states that, the IDF Diabetes Atlas (2013) estimate that there 
are 207,490 people with diabetes in Ireland in the 20 – 79 age group (a prevalence of 
6.5% in the population). This is in line with previous estimates that by 2020 there would 
be 233,000 people with the condition, and by 2030 there would be 278,850 people with 
the condition (a prevalence of 7.5% in the population) (International Diabetes 
Federation 2013) in Ireland. 
Worldwide statistics say one in twelve of the world population have diabetes which 
equates to approx. 387 million people with a prevalence of 8.3%. This is expected to 
increase by 205 million by 2035. It is also suggested that one in two don’t know they 
have diabetes and remain undiagnosed. Every six seconds one person dies from diabetes 
and there were 4.9 million deaths in 2014 directly attributed to the disease (International 
Diabetes Federation 2013). 
2.0.4 Economic cost of diabetes 
 
Diabetes can cause a variety of health complications for patients. It is responsible for 
many early deaths, reduced quality of life and significant costs to the health and social 
care system as well as the overall economy. The life expectancy of people with diabetes 
is shortened by up to 15 years, and 75% die of macrovascular complications (National 
Institute for Health Care Excellence 2016b). 
It is estimated that 10% of all people with diabetes will have a diabetic foot ulcer at 
some point in their lives. Diabetes is the most common cause of non-traumatic limb 
amputation, with diabetic foot ulcers preceding more than 80% of amputations in 
people with diabetes. After a first amputation, people with diabetes are twice as likely 
to have a subsequent amputation as people without diabetes. Mortality rates after 
diabetic foot ulceration and amputation are high, with up to 70% of people dying within 
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5 years of having an amputation and around 50% dying within 5 years of developing a 
diabetic foot ulcer (National Institute for Health Care Excellence 2016b). 
The budget for the Irish health service in 2014 was €12.774 billion. For 2015 there was 
an increase of Exchequer funding of €305 million, bringing the budget up to €13.079 
billion (Department of Health 2014). It is estimated that approx. In Ireland 10% of the 
total health budget is spent on diabetes - approx. €1.27 billion with a further estimate 
of 60% of this being spent annually on complications which includes foot ulcers (Nolan 
et al. 2006). The increasing economic burden of diabetes on our health care system is 
becoming a major challenge for the government.  
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2.1 Diabetes and the foot 
Foot ulcers can be complex and difficult to manage. The ever increasing diabetic group 
are the most complex and difficult patient cohort to manage when it comes to wounds 
and ulceration. 
Patients with diabetes run an increased risk of developing foot problems largely because 
of either diabetic neuropathy or narrowing of the arteries called peripheral arterial 
disease (PAD).  
PAD leads to a reduction in perfusion to the foot which in turn often leads to skin 
breakdown – see arterial ulceration, section 2.2. PAD affects 1 in 3 people with diabetes 
over the age of 50 (National Institute for Health Care Excellence 2016b). 
In patients with diabetes, they can often have a higher than normal blood sugar level so 
that over time nerves can become damaged (National Institute of Diabetes and 
Digestive and Kidney Diseases 2013).The increased blood sugar interferes with the 
ability of the nerves to transmit signals. Diabetes also weakens the walls of the small 
blood vessels (capillaries) that supply the nerves with oxygen and nutrients. This 
damage leads to a loss of sensation in the peripheries (hands and feet), and an inability 
to feel pain which is called peripheral or diabetic neuropathy. Peripheral neuropathy 
can also cause muscle weakness and hence a loss of reflexes, especially at the ankle, 
which can lead to changes in the way a patient walks. Foot deformities are common. 
Some patients have mild symptoms but for others they can be disabling and even fatal. 
Often symptoms develop gradually, and the patient may not notice problems until 
considerable damage has occurred. What can start out as a small cut, if it goes 
unnoticed, can eventually end up becoming severely infected. The risk of infection is 
high in this patient group, and if it develops to affect the bone, it can lead to tissue death 
(gangrene). In this case ulcers become impossible to treat and require amputation of a 
toe, foot or even the lower leg. From the above, it is easy to understand why people 
with diabetes are more prone to foot ulcers than other patient groups. Early detection 
of foot and skin sores is vital to help prevent infection and progression into full blown 
ulceration.   
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2.2 Ulceration 
The skin is tough, pliable and resistant to injury. In the case of it becoming injured or 
broken, it is generally very resilient and has an amazing ability to self-repair and heal. 
Despite this resiliency, the skin is unfortunately susceptible to breakdown if subjected 
to prolonged abuses such as excessive pressure, shear force, friction or moisture. Skin 
breakdown ranges from minor scrapes, cuts, tears, blisters or burns to the most serious 
pressure ulcers, with the destruction of tissue down to and even including the bone. 
Ulcers are wounds, open sores or simply a break in the skin that allow air and bacteria 
to get into the underlying tissue. They are a direct result of damage or destruction of 
the epidermis or dermis which can allow infection to manifest. This in turn can often 
lead to the wound not healing or for the wound to keep returning frequently. 
 
A      B 
Figure 2.2 A & B Diabetic foot ulceration  
In most people, small wounds or injuries heal up quickly and without any difficulty 
within a week or two. If there is an underlying problem, the skin does not heal and the 
area of breakdown can actually increase in size. This then becomes a chronic ulcer. 
There are many contributing factors for ulcer development including poor nutrition and 
hydration, weight, impaired circulation and oxygenation, substance abuse, depression, 
and age. Smoking, diabetes and other vascular conditions can lead to decreased 
circulation which increases the risk for skin breakdown. Diabetes is a leading 
underlying contributory factor. Chronic and non-healing wounds are problematic not 
only for the patient but also for the health care system. They can often lead to long 
hospitalisation periods due to slow healing. The complex diabetic patient group, with 
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their many risk factors affecting their ability to heal ulcers, can lead to a very lengthy 
and also very costly process for both the patient and health service. Research and health 
initiatives have been developing around foot protection and specifically in the 
prevention of problems rather that the treatment of them.  
One of the most important issues when it comes to ulcers is determining the cause and 
then ensuring the area is receiving enough nutrients to encourage and promote healing. 
Arterial disease accounts for approx. 15% of all leg ulcers with the remaining causes 
being venous disease (approx. 80%) with other causes such as diabetes, rheumatoid 
arthritis, malignancies and lymphoedema accounting for approx. 5% (Circulation 
Foundation 2016). In some cases two or more conditions can be attributed to the cause 
of the ulcer and hence to treat effectively it is important to diagnose at an early stage 
the type of ulcer present. Arterial ulceration and diabetes go hand in hand and so will 
be further discussed.  
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2.2.1 Atherosclerosis and arterial ulcers: 
 
Atherosclerosis is a systemic disease which affects the arteries. Fatty deposits called 
atheroma build up on the inside lining of the arteries which reduces the lumen of a 
vessel thus reducing the blood flow through the vessel.  
 
 
Figure 2.3 Normal versus a diseased artery  
 
A reduction in blood flow to various parts, in turn leads to a decreased oxygen supply 
to the tissue being supplied by that vessel. Arteries in the legs are commonly affected 
which in turn leads to poor perfusion of the feet. 
 
What causes atherosclerosis? The most commonly recognised risk factors in the 
development of atherosclerosis are smoking, diabetes, hypertension, 
hypercholesterolemia, lack of physical activity, family history, obesity and gender 
(National Institute of Health 2016). 
The restriction of blood flow to the legs and feet due to the build-up of atheroma on the 
arteries is called peripheral arterial disease (PAD). PAD can vary from mild to severe 
and it is important to assess prior to treating any patients presenting with ulceration. 
Patients with ulceration who have been diagnosed with severe PAD or critical lower 
limb ischaemia may progress to major limb loss unless successful surgical intervention 
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occurs. Blood pressure measurements are used to produce an index which indicates a 
percentage of blood flow to the area being examined. The baseline tests for patients 
suffering with PAD and/or ulceration is Ankle Brachial Indices (ABI’s) or Toe Brachial 
Indices (TBI’s). TBI’s are the standard test of choice in the diabetic patient group. Often 
in the diabetic patient group the tibial vessels are affected by calcification causing them 
to be falsely elevated or incompressible and so TBI’s are deemed to be more reliable as 
a marker of perfusion. This test is detailed in chapter 5, section 5.3.2.  
 
Work done by others has shown that in the diabetic patient group the risk of 
atherosclerotic disease is markedly increased. It is also noted that it can develop at an 
earlier age, be more severe and more diffuse making it very difficult to treat 
successfully (Marso S. P. Hiatt W. R. 2006).  
 
The measurement of TBI’s is a reproducible and quantitative test to assess arterial blood 
flow to the lower extremities. It is non-invasive and can diagnose the presence of PAD 
and determine its severity.  
 
 
  
15 
 
 
 
Chapter 3 
 
 
 
 
Lower limb arterial anatomy 
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Anatomy 
3.1 Anatomy of the human skin 
The skin is a vital organ that covers the entire outside of the body making it the body’s 
largest organ. It receives one third of the body’s blood circulation. It is comprised of 
two layers that cover a third fatty layer. These three layers differ in their function, 
thickness, and strength. The outer layer is called the epidermis - it is a tough protective 
layer that contains the melanin-producing melanocytes. The second layer (located 
under the epidermis) is called the dermis - it contains nerve endings, sweat glands, oil 
glands, and hair follicles. Under these two skin layers is the fatty layer of subcutaneous 
tissue, known as the subcutis or the hypodermis.   
 
Figure 3.1 Diagram of the skin 
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1) The Epidermis 
This is the outermost layer of the skin. The thickness of the epidermis varies in different 
types or location of skin. Its role is to form a protective barrier against pathogens and 
various injuries that could occur due to the environment. It shields the body against 
heat, light, injury, and infection. It also helps regulate body temperature, gathers 
sensory information from the environment, stores water, fat, and vitamin D, and plays 
a role in the immune system protecting us from disease. 
The epidermis itself is made up of five sub-layers that work together to continually 
rebuild the surface of the skin.  
The five sub-layers are as follows:  
i) The Basal Cell Layer  
This contains small round cells called basal cells which continually divide, with 
new cells constantly pushing older ones up towards the surface of the skin, where 
they are eventually shed. The basal cell layer contains cells called melanocytes 
which give the skin its colouring or pigment known as melanin. These also protect 
the deeper layers of the skin from the harmful effects of the sun.  
 
ii) The Squamous Cell Layer 
This is located above the basal layer. The basal cells that have been pushed upward, 
are maturing and become known as keratinocytes. These produce keratin, which is 
a tough, protective protein that makes up the majority of the structure of the skin, 
hair, and nails. This is the thickest layer of the epidermis.  
 
iii & iv) The Stratum Granulosum & the Stratum Lucidum 
The keratinocytes from the squamous layer are then pushed up through these two 
thin layers. As these cells move further towards the surface of the skin, they get 
bigger and flatter and adhere together, and then eventually become dehydrated and 
die. This process results in the cells fusing together into layers of tough, durable 
material, which continue to migrate up to the surface of the skin. 
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v) The Stratum Corneum 
This is the outermost layer of the epidermis, and is made up of 10 to 30 thin layers 
of continually shedding, dead keratinocytes. As the outermost cells age and wear 
down, they are replaced by new layers of strong, long-wearing cells.  
 
2) The Dermis 
The dermis is located beneath the epidermis and is the thickest of the three layers of the 
skin and makes up approximately 90 percent of the thickness of the skin. Its main 
function is to regulate temperature and to supply the epidermis with nutrient-saturated 
blood. The dermis layer is made up of two sub-layers. One is called the Papillary Layer 
which supplies nutrients to the epidermis and regulates temperature and the other is the 
Reticular Layer which strengthens the skin, to provide structure and elasticity.  
Much of the body's water supply is stored within the dermis. This layer contains most 
of the skins specialised cells and structures, including: 
 Blood vessels which supply nutrients and oxygen to the skin and take away cell 
waste and cell products 
 Lymph cells or capillaries are a network of tiny walled vessels which pick up 
fluid that leaks into the tissue from the blood stream and which is returned back 
to the circulatory system. 
 Hair follicles are a tube-shaped sheath that surrounds the part of the hair that is 
under the skin and nourishes the hair 
 Sweat glands which in the armpits and pubic region secrete a milky sweat that 
encourages the growth of the bacteria responsible for body odour. Other glands 
over the body regulate body temperature by bringing water via the pores to the 
surface of the skin, where it evaporates and reduces skin temperature.  
 Sebaceous glands secrete oil that helps keep the skin smooth and also helps 
keep skin waterproof and protects against an overgrowth of bacteria and fungi 
on the skin. 
 Nerve endings are pain and touch receptors that transmit sensations of pain, 
itch, pressure and information regarding temperature to the brain for 
interpretation 
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 Collagen is a protein made by fibroblasts that is found throughout the body in 
the connective tissues that hold muscles and organs in place.   
 Elastin, a similar protein that allows the skin to spring back into place when 
stretched and keeps the skin flexible. 
3) The Subcutis 
This is the innermost layer of the skin. It consists of a network of fat and collagen cells. 
It functions as both an insulator, conserving the body's heat and as a shock-absorber, 
protecting the inner organs. It also stores fat as an energy reserve for the body. The 
blood vessels, nerves, lymph vessels, and hair follicles also cross through this layer.  
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3.2  The Macrocirculation 
 
The macrocirculation is the circulation of blood through the larger vessels in the body 
- arteries and veins. The following section will detail the anatomy of the lower limb 
arteries.  
3.2.1 Anatomy of arteries 
Arteries are blood vessels within the body whose main function is to deliver oxygen-
rich blood from the heart to the various organs and tissues of the body. Arteries, despite 
their location in the body, have a similar structure. Each artery is a muscular tube lined 
by smooth tissue with three distinct layers: 
 The intima 
The intima is the inner layer which is lined by a smooth tissue called endothelium. This 
is composed of a thin layer of endothelial cells and lines the entire circulatory system 
from your heart to the large arteries, right all the way down to the very tiny capillary 
beds.  
 The media  
The media is composed of a smooth layer of muscle fibres surrounded by fibrous tissue 
which allows the arteries withstand the high pressures from the heart. This muscular 
layer permits the arteries to constrict and dilate to adjust the volume of blood needed 
by the tissues that they feed.  
 The adventitia 
The adventitia is the outermost layer and it is used to attach the vessel to the surrounding 
tissue. This layer is composed of connective tissue with varying amounts of elastic and 
collagenous fibres 
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Figure 3.2 Layers of the artery  
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3.2.2  The lower limb arterial anatomy 
The largest artery in the body is the aorta. It is connected to the heart's left ventricle and 
it carries oxygenated blood around the body. It has many branches which feed all the 
various abdominal organs. At L4 or the level of the umbilicus, the aorta divides into 
two main branches – these are called the common iliac arteries (CIA). At the brim of 
the pelvis the CIA further branches into the internal (IIA) and external iliac arteries 
(EIA). The IIA supplies the pelvis muscles. The EIA descends to groin level and 
becomes the common femoral artery (CFA). See figure 3.3 below.  
 
Figure 3.3 The iliac arteries  
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The CFA just below groin level divides to become the profunda femoris (PFA) and the 
superficial femoral artery (SFA). The PFA supplies the thigh muscles. The SFA 
continues to knee level and becomes the popliteal artery (PA). Just below knee crease 
level, the anterior tibial artery (ATA) arises off the PA and this vessel runs on the lateral 
aspect of the calf to ankle level where it continues into the foot as the dorsalis pedis 
artery (DPA). The PA continues after the ATA take off as the tibioperoneal trunk 
(TPT). The TPT divides into the posterior tibial artery (PTA) and the peroneal artery 
(PER). See figure 3.4 below.  
 
 
 
Figure 3.4 The lower limb arteries 
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The PTA supplies blood to the posterior calf muscles and plantar surface of the foot. It 
gives rise to the medial and lateral plantar arteries. The PER supplies blood to the calf 
and ankle muscles. It divides on the lateral aspect of the foot and forms the external 
malleolus artery, lateral tarsal artery and external plantar artery. The plantar arteries, 
lateral, medial and deep form a looping web across the foot and down through each toe.  
 
Figure 3.5 The foot arteries  
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3.3 The Microcirculation 
 
Blood circulates from the heart to the arteries, to arterioles (small arteries), to 
capillaries, to venules (small veins), to veins and back to the heart. The microcirculation 
is the circulation of the blood in the smallest blood vessels, the main function of which 
is to deliver oxygen (O2) and nutrients and to remove carbon dioxide (CO2). Essentially 
it is responsible for the regulation of tissue perfusion. It also serves to regulate blood 
flow and tissue perfusion which can affect blood pressure and the body’s responses to 
inflammation such as oedema.  
It is composed of terminal arterioles, capillaries, and venules that drain capillary blood.  
Arterioles: These are the vessels on the arterial side of the microcirculation. They are 
surrounded by smooth muscle cells and measure approx.10-100µm in diameter. They 
contract and relax their diameter in response to a diverse range of stimuli, which means 
blood flow in the microcirculation remains constant despite changes in systemic blood 
pressure. They are responsible for carrying the blood to the capillaries. 
Capillaries: These have no smooth muscle cells and measure between 5-8µm in 
diameter. Approximately 7% of the body’s blood is in the capillaries and this is where 
the exchange of substances occurs. Precapillary sphincters control the flow of blood 
between the arterioles and the capillaries. The displacement of materials between the 
interstitial fluid and the blood is called the capillary exchange. The precapillary 
sphincters contain muscle fibres allowing them to contract. If the sphincters are open 
blood can flow freely to the capillary bed which is where fluids, gasses, nutrients and 
wastes are exchanged between the blood and the body cells. If the sphincters are closed 
blood cannot flow through the capillary bed and must flow directly from the arteriole 
to the venule.  
Venules: Blood then flows out of the capillaries and into the venules, which have a 
little smooth muscle and are approx. 10-200µm in diameter. The blood flows from the 
venules into the veins. In addition to these blood vessels, the microcirculation also 
includes lymphatic capillaries and collecting ducts.  
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Figure 3.6 The microcirculation in the foot  
 
Blood is supplied to all parts of the body at all times but all capillary beds do not contain 
blood at all times. Blood is diverted to the various parts of the body that require it most, 
at a particular time.  
 
One of the most important issues when it comes to ulcers is firstly determining the cause 
and then ensuring that the area is receiving enough nutrients to encourage and promote 
healing.  
 
Transcutaneous oximetry (tcpO2) is considered the gold standard for assessment of 
tissue oxygenation, an essential test in assessing the probability of wound healing (Lee 
Y.N. et al. 2014). tcpO2 is a local non-invasive measurement reflecting the amount of 
O2 that has diffused from the capillaries through the epidermis to a Clark-type electrode 
at the measuring site. It provides instant continuous information about the body’s ability 
to deliver oxygen to the tissue and thereby measures nutritive blood perfusion at a given 
site. With the current emphasis on cost savings in the health service, this non-invasive 
test is gaining importance as a tool for predicting healing. Physicians use this data to 
aid decision making with regards to treatment plans for their patients. In being able to 
determine the tissue oxygenation status of a wound area, the physician can out rule any 
treatment options which would be ineffective and move directly for the quickest most 
efficacious treatment. The microcirculation is important to consider in the diabetic 
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patient group especially in the cases where traditional tests such as TBI’s aren’t possible 
due to ulceration or previous amputation.  
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Chapter 4 
 
 
 
 
Physics and Instrumentation  
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4.0 Physics 
 
The following chapter looks at the physics behind ultrasound and the basic principles 
used in measuring the flow or velocity of flow in the lower extremities.  
4.0.1 Soundwaves 
 
Soundwaves are described as mechanical vibrations of particles or molecules within a 
medium. The vibration of one particle transmits a corresponding vibration to an 
adjacent particle and so a wave is passed through a medium. The transmission of a 
soundwave through a medium occurs at a fixed speed which is determined by the 
elasticity and density of a particular medium. Frequency or pitch is described as the rate 
at which an individual particle vibrates. This is measures in Hertz (Hz) and is the 
number of cycles per second.   
Ultrasound is defined as sound which has a frequency above the audible range of 
humans which is greater than 20 kHz.  
Soundwaves have a longitudinal, sinusoidal waveform which varies from high 
pressures (compression) to low pressure (rarefaction). Wavelength is the distance 
between identical points in a cycle. 
 
 
 
Figure 4.1 A Soundwave   
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4.0.2 The Doppler Effect 
 
The Doppler Effect was first described by an Austrian physicist, Christian Andreas 
Doppler in 1842. It is described as a shift in the observed frequency of a radiated wave 
motion when there is movement between the source of the radiation and the observer. 
The classic example is an ambulance siren. This sounds higher pitched when it is 
travelling towards you and lower pitched when travelling away.  
 
 
Figure 4.2 The Doppler Effect  
 
If the source and the observer are both stationary, then emitted waves travel through 
the intervening medium at a constant and regular rate, and pass the observer at the same 
rate as transmitted. If the source is moving towards a stationary observer, the 
wavelength becomes shorter as the source gets closer, and even though they pass the 
observer at the same speed, the observer experiences a higher frequency. Conversely if 
the source is moving away from the observer, the wavelength is increased and the 
observer experiences a lower frequency.  
If the observer is moving towards a stationary source, the observer intercepts the waves 
at a faster rate, and experiences a higher frequency. Conversely if the observer is 
moving away from a stationary source, they intercept the waves a slower rate, and 
experience a lower frequency.  
In the case of both a moving source and a moving observer, the difference between both 
the transmitted and received frequencies of the waveforms is called the Doppler Shift. 
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This can be positive or negative depending on whether the blood flow is going towards 
the transducer or away from it.  
In vascular ultrasound the Doppler shift frequency provides the basis for calculating the 
velocity of flow in the vessel under investigation. It falls within the audible hearing 
range of the human ear and so the pitch can be heard by the physiologist. The method 
of applying the Doppler principle in ultrasound differs from the original theory in that 
the moving targets are blood cells, so that the transducer is both the source and the 
receiver. The reflected or scattered waveform and the corresponding change in 
frequency can be observed with the difference between the transmitted and received 
frequencies being referred to as the Doppler shift frequency (fd).  
 
Equation 4.1     Fd = 2ft V Cos θ    
The Doppler shift frequency           C 
  
     
 
ft= the frequency emitted by the transducer 
θ = the angle between the Doppler bean and the direction of flow 
C = velocity of sound in the medium – approx. the same in all soft tissue (1540 m s-1) 
V = the blood cell velocity 
 
The angle of insonation (θ) is very important in the clinical use of Doppler. If θ = 0°, 
Cos θ = 1 and the maximum Doppler shift frequency is obtained for a given velocity. 
As θ increases the value of Cos θ decreases and hence the Doppler shift frequency 
decreases until at θ = 90° (Cos θ = 0) and there is no Doppler shift at all and no audible 
signal. To obtain reliable quantitative Doppler data in clinical practice, θ should not 
exceed 60°. (The Society for Vascular Technology of Great Britain & Ireland 2001). 
 
32 
 
 
Figure 4.3 The Angle θ  
 
The use of Doppler in clinical investigations was not accomplished until the 1960’s 
with the development of the first Doppler probe by Satomura in 1959 (Coman I.M. 
Popescu B.A. 2015). 
Currently Doppler ultrasound is routinely used as a non-invasive test to examine and 
evaluate the movement of blood flow through arteries and veins. It enables medical 
staff to diagnose multiple conditions such as arterial narrowing, deep vein thrombosis, 
heart and numerous organ defects.    
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4.1 Instrumentation  
 
This section will discuss the actual equipment used in practice to assess perfusion, both 
with regards to actual blood flow and also oxygenation of tissue.  
4.1.1 Doppler Instruments 
 
In clinical practice there are two types of Doppler instrumentation – continuous wave 
(CW) and pulsed wave (PW). These can also be described as either imaging or non-
imaging. Non-imaging techniques (CW) include the traditional hand held continuous 
wave Doppler units used in the detection of peripheral pulses. These are used when 
preforming Ankle Brachial Indices (ABI’s) or when recording the Brachial systolic 
pressure for a set of TBI’s. Imaging techniques include colour Doppler, power Doppler 
and spectral pulsed wave Doppler and are always used in conduction with B-Mode 
imaging used in general ultrasound. 
 
Continuous Wave Doppler are the simplest Doppler devices available and are 
typically a hand held unit with a pencil probe attached. 
 
 
 
Figure 4.4 Image of CW pencil probe  
 
The pencil probe transducer consists of two piezoelectric elements or crystals mounted 
on the end. One crystal acts as the emitter and the other one as the receiver. The two 
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crystals are set at angles to each other so that the emitted and received beams overlap 
or converge to form a long narrow crossover region. This is where the Doppler signal 
can be detected. The detected signal is obtained from all the moving targets passing 
through this region. Continuous wave devices are widely used today and have many 
clinical applications such as foetal heart monitoring and the detection of peripheral 
pulses. However, their main disadvantage is that any sound detected in the crossover 
region can be heard by the operator. For example flow from more than one vessel may 
be heard at the same time such as an artery and a vein, resulting in a mixed arterial and 
venous signal being detected. The biggest advantage is that they are inexpensive and 
easy to use by a skilled operator. 
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4.1.2 Photo Plethysmography (PPG) 
 
Photoelectric plethysmography is used to obtain the systolic pressures at the toe when 
performing a TBI exam. The sensor of the PPG contains an infrared light which has 
an emitting diode and a phototransistor. When this sensor is placed on the limb, the 
infrared light is transmitted into the superficial layers of the skin and the reflected 
portion is received by the phototransistor.  
 
 
 
Figure 4.5 Image of PPG  
 
The resulting signal is proportional to the quantity of red blood cells in the cutaneous 
circulation i.e. it measures changes in light absorption (Zwiebel W.J. and Pellerito J. 
2000). 
A conventional pulse oximeter monitors the perfusion of blood to the dermis and 
subcutaneous tissue of the skin. PPG is a low cost and simple technique used to detect 
blood volume changes. It is non-invasive and in recent years there has been a resurgence 
of interest in the technique and its applications in a clinical setting.  
The PPG waveform comprises a pulsatile waveform superimposed on a slowly varying 
baseline with various lower frequency components. The pulsatile one is attributed to 
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cardiac changes in the blood volume with each heartbeat, and the second one is 
attributed to respiration, sympathetic nervous system activity and thermoregulation. 
The below diagram figure 4.6 shows a typical PPG signal without motion artefact.  
 
 
Figure 4.6 PPG Waveform  
PPG technology is being used in a wide range of commercially available medical 
devices for measuring oxygen saturation, blood pressure and arterial stiffness, cardiac 
output, assessing autonomic function and detecting peripheral vascular diseases (Allen 
J. 2007). For our purposes we use it for measuring blood perfusion in the toes.  
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4.1.3  The Clark Electrode 
 
Lealand C Clark is responsible for the development of this electrode and it is used to 
quantify or measure oxygenation tension at a particular point on the skin. In the field 
of vascular diagnostics it is used in the tcpO2 test. A transcutaneous oximeter uses a 
clarkpolarographic electrode which is modified to contain both a heating element and 
a thermistor.  
The heating element maintains a pre-set temperature of 42 – 45°C. 
The role of the thermistor is to continuously monitor this.  
A phosphate buffer and a potassium chloride solution is contained between the 
electrode surface and an oxygen permeable membrane.  
 
 
Figure 4.7 Clark-type electrode 
(A) Pt- (B) Ag/AgCl-electrode (C) KCl electrolyte (D) Teflon membrane (E) rubber 
ring (F) voltage supply (G) galvanometer 
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The electrode is attached to the skin by an adhesive fixation ring which is then filled 
with the contact solution. This maintains a continuous liquid pathway for the oxygen to 
diffuse from the skin to the electrode. A constant polarizing voltage is applied to the 
cathode within the sensor. The polarized oxygen electrode provides electrons to reduce 
molecular oxygen as it arrives at the electrode surface. Separate to the polarizing 
voltage an extra current is derived from the reduction of oxygen at the electrode surface 
as the oxygen is converted to hydroxyl ion. The current generated is directly 
proportional to the number of oxygen molecules in the solution. Hence the oxygen 
sensor can be used to determine the oxygen tension in the skin capillaries.  
 
 
 
 
Figure 4.8 Image of tcpO2 probe  
 
This chapter outlined the basic physics principles and the practical application of both 
the ultrasound and oximetry modalities. The next section, chapter 5, method of data 
acquisition, will outline patient selection parameters and the process of the utilisation 
of these modalities in providing quantitative and qualitative data.   
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Chapter 5 
 
 
 
 
Method of data acquisition 
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5.1 Methology 
In 2008 Tallaght hospital introduced a new multidisciplinary diabetic foot protection 
clinic (DFPC). This clinic focused on treating and managing diabetic patients with 
existing ulceration. Every patient attending the clinic had access to Endocrinology, 
Orthopaedic Surgery, Podiatry, Orthotics, Tissue Viability and Vascular Surgery in a 
“one stop shop” environment. Results from between 2006 and 2010 showed a total of 
221 lower limb procedures were performed. The number of amputations decreased 
from 12 during the control period (2006 – 2008) to 7 in the study period (2008 – 2010). 
On costing the clinic activity there was an overall saving of €114,063 per years 
associated with the introduction of the DFPC (Nason G.J. et al. 2012). 
In 2012 the vascular laboratory sought to further enhance the diagnostic services it 
offers, in a bid to improve the support it provides to this clinic and indeed ulcer patients. 
The complexity of the patients presenting with ulceration was noted to include toe 
amputations and/or ulcers often preventing the standard TBI test from being performed. 
This led to an alternative test being sought to help with this patient cohort. There are 
several factors that can influence the wound healing process and one such factor is 
tissue oxygenation surrounding the wound, thus an adequate oxygen supply is essential.  
This study was undertaken to audit results from a test introduced into the vascular 
service in December 2012 called transcutaneous oximetry (tcpO2). tcpO2 is a 
measurement of tissue oxygenation at a particular site. It has been growing in 
recognition as a test to help aid a doctor’s decision in predicting healing or whether an 
amputation will be the end result. In practice, patients often require an admission to 
hospital to observe wound healing and investigate the initial cause of the wound. Those 
failing to progress during admission, or those who fail to heal post intervention and/or 
discharge, often require readmission for further procedures. Given the introduction of 
this test did not cost the hospital with regards additional staffing or space, and only 
required minimal training, the question is, has the introduction of this test provided any 
clinical diagnostic value?   
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5.1.1 Patient selection 
For the purposes of this study, patients were selected from a population which presented 
to both the vascular surgical outpatients (OPD) and the diabetic foot protection clinic 
(DFPC) with ulceration to a lower limb. Inpatients were also included who were 
admitted under the care of the vascular team for treatment of an active ulceration. 
Patients were only included in the audit if they had both tests performed ie. a set of 
TBI’s and a tcpO2 exam. Both diabetic and non-diabetic patients were included and in 
some cases both the limb with ulceration and the contra-lateral limb had tcpO2 
performed. 
The medical history of all patients was reviewed and noted to include the following 
details 
i) Smoker / ex-smoker / non-smoker 
ii) Medicating to treat hypertension 
iii) On statin therapy 
iv) Diabetic and if so whether Type 1 or Type 2 
It is widely accepted that these characteristics are known to be commonly associated 
with vascular disease and as previously outlined in chapter 2 section 2.1 vascular 
disease can be prevalent in the diabetic ulcer patient.  
All results have been collated for the three year period and analysed.  
Of note it is important to recognise that there may have been limitations within the 
study with regard to patient compliance with medications. Patients may have been 
hypertensive or hypercholesteraemic despite attempts at best medical management. It 
was not possible to quantify patient compliance with medical advice and medication 
requirements. It also cannot be ruled out if there were undiagnosed diabetics within the 
study. As discussed in section 2.0.3 there are significant numbers of undiagnosed 
diabetics in both Ireland and worldwide. There may also be limitations with regard to 
smoking status within the study. It is difficult to qualify the smoking status of patients 
and indeed this is a major challenge across many areas of healthcare.   
42 
 
5.2 Demographics 
Demographics are divided into two groups 
1) 5.2.1 analyses participant demographics 
2) 5.2.2 analyses test variables. 
 
5.2.1 Participant demographics 
 
In the audited time frame, December 2012 – December 2015, there were a total of 247 
patients with ulceration which attended the vascular laboratory who had a tcpO2 exam 
performed. This number of patients represented 48% of all ulcer patients that attended 
the laboratory in this time period. The other 52% of patients had a TBI exam only. 
There was no formal criteria or protocol established for ordering tcpO2 as this was a 
trial period to investigate the usefulness of the test itself.  The placement of requests for 
tcpO2 exams were consultant led and determined by a clinical decision made by the 
vascular consultant bearing in mind the limited resources, primarily time, available. 
These patients represented approx. 14% of all patients going through the laboratory for 
the investigation of peripheral vascular disease. The inclusion criteria for this study was 
any person with an ulceration presenting to the vascular laboratory between December 
2012 – December 2015 who had both a tcpO2 test performed and a corresponding TBI 
test. The age range was 32 – 94 years old with a mean age of 67.5years and a median 
age of 69 years. Of these patients 163 (66%) were male and 84 were female (34%),  
 
 
5.2.2 Test variables 
 
Of the 247 patients, 105 of them had tests performed bilaterally accounting for 210 
tests. There were 142 single leg tests which resulted in an overall total of 352 tests 
performed. Of these, 42 tests were excluded from the initial analysis – 30 tests had no 
corresponding TBI’s or absolute toe pressure (ATP) as a result of a toe or transmetarsal 
amputation (TMA), incompressible vessels, or due to excessive patient movement. A 
further 12 tests were excluded as these patients went directly to theatre and were only 
seen post intervention. This resulted in a total number of 310 tcpO2 tests in the three 
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year period which had a corresponding set of TBI’s performed. These were 
retrospectively analysed.  
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All statistical analysis was carried out on the total numbers of tests. See table figure 5.2.  
  
 
Table 5.1 Test variables 
 
Seventy seven (25%) tests were carried out on current smokers and two hundred and 
thirty three (75%) were current non-smokers with one hundred and twenty five of these 
being ex-smokers. There were 238 (77%) tests carried out on patients who were 
medicating for the treatment of hypertension and 215 (69%) on statin therapy. A total 
of 228 tests (74%) were performed on ulcerated limbs. Two hundred and four (66%) 
tests were carried out on patients who were diagnosed as diabetic with 36 (18%) who 
were classed as Type 1 and 168 (82%) as Type 2. There were 106 (34%) tests carried 
out on non-diabetics.  
   
n
Tests for analysis 310
Male 204
Female 106
Current Smoker 77
Current Non Smoker 233
Hypertension 238
No hypertension 72
Statin Therapy 215
No Statin Therapy 95
Ulceration 228
No Ulceration 82
Diabetic 204
Type 1 36
Type 2 168
Non Diabetic 106
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5.3 Assessment of Lower limb arterial disease 
All patients had 2 test performed, tcpO2 and a set of toe Brachial indices (TBI’s).  
5.3.1 Transcutaneous Oxygen Pressure (tcpO2) 
tcpO2 is a well-established non-invasive method which quantifies the amount of oxygen 
that diffuses from the capillaries and through the skin and only reflects the status of the 
capillaries i.e. nutritive flow.  
 
Patient Preparation 
No specific preparation was required on behalf of the patient for this test. Shoes, socks 
and any bulky clothing on their upper body were removed. The test was explained in 
full to the patient and any questions were answered. Patients lay supine on an 
examination couch.  
Equipment  
All tcpO2 tests were carried out on a Radiometer TCM400 machine.   
 
 
Figure 5.1 tcpO2 machine  
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Electrode prepared / calibrated  
All electrodes being used were placed in the channel on the machine and calibrated.  
 
Method for performing tcpO2 
1. Patients were examined while lying supine.  
2. The sensor site was located. A single standardised location for positioning of the 
sensor was chosen on all patients (where possible). This was on the dorsum of the foot. 
It was important that this site did not directly overlie a bony prominence or any 
superficial vessels. Flat or convex areas were most reliable. If it was not possible to use 
this site due to an area of ulceration the site nearest it was used.  
 
 
Figure 5.2 Picture of tcpO2 probe in situ  
 
3. The site was then prepared as follows. The chosen area was stripped with adhesive 
tape to remove any loose skin cells. Any hair was removed if deemed necessary. The 
area was cleaned with an alcohol wipe. Any open skin areas were avoided.  
4. The fixation ring was then attached using its adhesive backing.  
5. The centre of the fixation ring was pressed onto the measuring site with a finger and 
a finger was ran around the rim circumference.  
6. It was important that the placement was completely airtight.  
7. Approx. 4 - 5 drops of contact liquid was then placed in the fixation ring and the 
electrode was then attached by aligning the arrow on the sensor with the mark on the 
fixation ring. 
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8. The sensor was turned 90o clockwise to fasten it in place securely. It was important 
that this connection was also airtight. To increase the permeability of the skin to oxygen 
molecules at the measuring site, the sensor maintained a pre-set temperature of 43 – 
45oC. 
9. The test was performed for 20 minutes. As per supplier protocol 20 minutes was 
adequate physiological stabilisation time for an accurate reading. This time allowed the 
sensor to heat the skin and encourage the arteries dilate. Results were recorded at the 
end of this period.  
10. In the case where the reading at the end of the 20 minutes period was less than 
40mmHg the patient was given 5L of 100% oxygen per minute through a rebreather 
mask and the test continued for a further 10 minutes.  
Results were also recorded at the end of this period.  
 
Interpretation of tcpO2 measurements 
A baseline measurement of < 40mmHg was selected as the cut-off below which the test 
was considered as abnormal and indicative that a wound could be unlikely to heal.  
A baseline measurement of > 40mmHg was selected as the cut-off above which there 
should be spontaneous wound healing.  
It has been previously determined that values near the wound that are below 40mmHg 
are considered to have moderate – severe hypoxia and are potential candidates for 
aggressive wound healing and / or revascularisation (Sheffield P.J. 2004). 
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5.3.2 Toe Brachial Indices (TBI’s) 
Patient Preparation 
No specific preparation was required on behalf of the patient for this test. Shoes, socks 
and any bulky clothing on their upper body were removed.  The test was explained in 
full to the patient and any questions were answered.  
 
Equipment  
All TBI’s were carried out on an Elcat Vasolab 320 machine. 
Two standard blood pressure arm cuffs were used as were two 2.5cm toe pressure cuffs. 
An 8MHz continuous wave Doppler probe was used to insonate the Doppler waveform 
in the Brachial artery (BA) in each arm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                             
Figure 5.3 Picture of TBI and PPG machine  
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Method for performing a TBI  
1. Patients were examined while lying supine.  
2. A pneumatic cuff was carefully placed around each of the patient’s arms. 
 
Figure 5.4 Picture of arm cuff in situ 
 
The end of an 8MHz continuous wave Doppler probe was covered in ultrasound gel 
and the BA in each arm was insonated.  
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3. While the probe was held static and the physiologist listened to the BA Doppler 
signal, the pneumatic cuff was inflated until the signal was inaudible. This indicated 
the occlusion of the artery. 
4. The cuff was then slowly deflated until the BA Doppler signal returned sharply. The 
systolic pressure reading at this point was recorded and the remainder of the air in the 
cuff was rapidly deflated. 
5. Steps 2 to 4 were repeated for the left arm. 
6. A toe cuff was attached to each of the patient’s hallux and the photoplethysmogram 
(PPG) sensor was also attached. The pressure in both hallux was recorded 
simultaneously. 
 
 
 
 
Figure 5.5 Picture of toe cuff and PPG in situ  
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7. When a steady arterial waveform was displayed on the screen, the cuff was inflated 
until the waveform was obliterated indicating occlusion of the digital artery 
8. The cuff was then slowly deflated until the waveform reappeared. The systolic 
pressure reading at this point of return was recorded. 
 
Interpretation of Toe Brachial Measurements 
In the normal limb the baseline digital index should be greater than or equal to 0.6 
(Cole, Norris and Walker. 2000). TBI’s are calculated as described in equation 5.1 
below. If PAD is present this value will drop accordingly to its severity.  
 
Equation 5.1   TBI =  Toe systolic pressure 
Highest Brachial systolic pressure  
 
A systolic toe pressure measurement of < 30mmHg indicates the presence of critical 
ischemia (Society for Vascular Technology of Great Britain and Ireland 2001). 
The digital arteries in the great toe are less affected by arterial calcification. However, 
this test is limited if the great toe has a wound/ulcer or there has been a previous 
amputation. Interpretation of toe pressure and TBI vary in the literature. In general, an 
absolute toe pressure (ATP) > 70 mmHg or a TBI > 0.6 is normal, with anything below 
these are diagnostic of PAD (Society for Vascular Technology of Great Britain and 
Ireland 2001). 
In the diabetic group, the microcirculation often also needs to be assessed and may 
provide alternative diagnostic information not possible to obtain due to amputation or 
ulceration from the usual tests such as TBI’s. Increasingly the laboratory has more 
patients attending who have had previous amputations and so this alternative test is 
required.   
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Chapter 6 
 
 
 
 
Comparison of risk factors between 
tcpO2 versus the absolute toe pressure 
results. 
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Comparison of risk factors between tcpO2 versus absolute toe pressure 
(ATP) results 
 
6.1  Aim 
The aim of this chapter is to statistically analyse the results from the two tests 
performed, TBI’s and tcpO2, and to assess the various risk factors of smoking, 
hypertension, statin therapy and diabetes i.e. does a relationship exist between these 
factors relative to the results? 
 
6.2  Method 
Statistical analysis of initial test results looked at all tests in the 3 year period. The 
objective of this statistical analysis was to determine if the average outcomes of the two 
sets of data are significantly different from each other. 
 
Initially, the distribution of results was visually assessed for each group being tested. 
This visual assessment was conducted to understand how best to statistically assess for 
differences. The distributions of test groups were seen to converge to a normal 
distribution though slightly skewed in some cases.  
It is also important to state that results are applicable to ulcer patients and not to the 
wider population in general.  
 
Given that the objective remains to compare an outcome and that the assumption of 
normality is less important as sample size increases (Lumley T. 2002), it was decided 
to use student’s t tests in all cases to test for differences in the means. The tests were 
evaluated at a 99% significance level (p-value < 0.01) to provide a stronger degree of 
certainty in the results compared to a more widely used 95% significance level. 
All analysis was performed using Microsoft excel 2013.  
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6.3  Results 
All risk factors were assessed and compared with regards to both tests.  
 
Smoking  
Test tcpO2 (mmHg)  ATP (mmHg) 
Smoker 34 56 
Non Smoker 41 72 
P-Value p = 0.006 p = 0.01 
Outcome Indicated difference Indicated difference 
 
Table 6.1 Analysis of smokers V’s non-smokers.  
 
Mean (± SD) tcpO2 between the smokers and the non-smokers were as follows: 
Smokers 34 ± 20 mmHg and the non-smokers 41 ± 19 mmHg.  
There was an indicated difference (p = 0.006) between the mean tcpO2 in smokers and 
the mean tcpO2 in the non-smokers. 
 
Mean (± SD) absolute toe pressures between the smokers and the non-smokers were as 
follows: 
Smokers 56 ± 55 mmHg and the non-smokers 72 ± 46 mmHg. 
There was an indicated difference (p = 0.01) between the mean absolute toe pressures 
in smokers and the mean absolute toe pressures in the non-smokers.  
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Hypertension  
Test tcpO2 (mmHg)  ATP (mmHg) 
Hypertension 38 64 
Non Hypertension 43 83 
P-Value p = 0.08 p = 0.003 
Outcome No indicated difference Indicated difference 
 
Table 6.2 Analysis of those medicating for hypertension V’s those not medicating 
for hypertension 
 
Mean (± SD) tcpO2 between patients medicating for hypertension and those not 
medicating for hypertension were as follows: 
Those on anti-hypertensive medications 38 ± 20 mmHg and those not on anti-
hypertensive medications 43 ± 18 mmHg.  
There was no indicated difference (p = 0.08) between the mean tcpO2 in those on anti-
hypertensive medications and those who were not. 
 
 
Mean (± SD) absolute toe pressures between patients medicating for hypertension and 
those not medicating for hypertension were as follows: 
Those on anti-hypertensive medications 64 ± 48 mmHg and those not on anti-
hypertensive medications 83 ± 50 mmHg.  
There was an indicated difference (p = 0.003) between the mean absolute toe pressures 
in those on anti-hypertensive medications and those who were not. 
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Statin therapy 
 
Test tcpO2 (mmHg)  ATP (mmHg) 
Statin therapy 39 64 
Not on statin therapy 40 77 
P-Value p = 0.56 p = 0.03 
Outcome No indicated difference No indicated  difference 
 
Table 6.3 Analysis of those on statin therapy V’s those not on statin therapy  
 
Mean (± SD) tcpO2 between patients on statin therapy and those not on statin therapy 
were as follows: 
Those on statin therapy 39 ± 20 mmHg and those not on statin therapy 40 ± 20 mmHg.  
There was no indicated difference (p = 0.56) between the mean tcpO2 in those on statin 
therapy and those not. 
 
Mean (± SD) absolute toe pressures between patients on statin therapy and those not on 
statin therapy were as follows: 
Those on statin therapy 64 ± 47 mmHg and those not on statin therapy 77 ± 53 mmHg.  
There was no indicated difference (p = 0.03) between the mean absolute toe pressures 
in those on statin therapy and those not.  Of note, if the standard p value of <0.05 was 
used, this may of suggested a difference between the groups 
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Diabetes  
 
Test tcpO2 (mmHg)  ATP (mmHg) 
Diabetic 39 68 
Non Diabetic 40 68 
P-Value p = 0.73 p = 0.96 
Outcome No indicated difference No indicated difference 
 
Table 6.4 Analysis of diabetics V’s non-diabetics  
 
Mean (± SD) tcpO2 between patients who are diabetic and those who are not were as 
follows: 
Patients who are diabetic 39 ± 20 mmHg and those who are not 40 ± 19 mmHg.  
There was no indicated difference (p = 0.73) between the mean tcpO2 in the diabetic 
and the non-diabetic patients. 
 
 
Mean (± SD) absolute toe pressures between patients who are diabetic and those who 
are not were as follows: 
Patients who are diabetic 68 ± 49 mmHg and those who are not 68 ± 50 mmHg.  
There was no indicated difference (p = 0.96) between the mean ATP’s in the diabetic 
and the non-diabetic patients. 
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6.4  Discussion 
 
This diagram, table 6.5, is a summary of the statistical analysis outcomes detailed in 
the previous section.  
Tests tcpO2 ATP 
  
Indicated 
difference 
No indicated 
difference 
Indicated 
difference 
No indicated 
difference 
Smokers V non-smokers √   √   
HTN V's no HTN    √ √   
Statins V's no Statins   √  √  
Diabetes V's no diabetes   √   √ 
 
Table 6.5 Summary of statistical analysis per risk factor 
The analysis in section 6.3, has shown that there is an indicated difference in the mean 
ATP’s and tcpO2 results between the smoking and the non-smoking groups. When 
comparing the smokers against the non-smokers with regards outcomes of these two 
tests, the results in the smokers in both tests are significantly lower than in the non-
smokers. This outcome supports evidence that smoking impairs the body’s ability to 
deliver oxygen effectively (Lee C.L. Chang W.D 2013, Nadel J.A. Comroe J.H. 1961) 
and is a significant factor in PAD due to atherosclerosis of the lower limb arteries.  This 
ultimately can lead to ulceration.  
The smoking prevalence in Ireland in 2015 was 19.2%, with the levels of smoking 
highest in younger adults aged between 18 – 24 years at 27.2% and in the 25 – 34 year 
olds at 28.5%. The lowest prevalence was in the over 65 year olds at 8.6% (Health 
Service Executive 2015). There are estimated to be 5500 smokers dying each year from 
tobacco related diseases (Health Service Executive 2016). This represents 
approximately 19% of all deaths. Of these deaths, 30% are attributed to circulatory 
diseases (U.S. Department of Health Human Services 2014).  
Cigarettes are known to contain over 4000 toxic chemicals (Ginzel K.H. 2016). 
Nicotine is one of the main ingredients in a cigarette and this is a highly addictive 
substance. It is also a vasoconstrictor which is known to increase the adhesiveness of 
platelets in the blood, hence raising the risk of a microvascular occlusion. This in turn 
can lead to a reduction in nutritional blood flow to the skin. Another substance in 
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cigarettes is carbon monoxide. This poisonous gas binds itself to the haemoglobin in 
the bloodstream and prevents it from carrying enough oxygen around the body.  
The association between cigarette smoking and delayed wound healing is well 
recognised (Silverstein P. 1992) and frequently leads to impaired perfusion. Smoking 
is also known to raise blood pressure which is a risk factor for other diseases such as 
stroke and heart attack.  
Statistical analysis in Section 6.3 shows that there was an indicated difference noted 
between the ATP’s in those on antihypertensive medications and those not. The ATP’s 
were lower in those tests taking hypertensives. There was no difference noted in the 
tcpO2 tests in either those medicating or those not, suggesting, that in this study 
hypertensive medications did not appear to affect oxygenation of the tissue.  
Antihypertensives are a drug used to treat hypertension – high blood pressure. There 
are many classes of this drug type, which are used to lower the blood pressure by 
different means. The most commonly used drugs are calcium channel blockers, 
angiotensin-converting-enzyme (ACE) inhibitors, diuretics and beta blockers. The type 
of medication initially chosen to treat hypertension has been the subject of several large 
studies and resulting national guidelines such as the AASK trial (African American 
study of kidney disease and hypertension), ALLHAT trail (antihypertensive and lipid 
lowering treatment to prevent heart attack trial), NICE (National institute for healthcare 
and care excellence), and JNC8 (Eight joint national committee on the prevention, 
detection, evaluation and treatment of high blood pressure) to name a few (Dewland 
T.A. et al. 2016, James P. A. et al. 2014, National Clinical Guideline Centre 2011, 
Norris et al. 2006). These trials looked at the various methods used to treat 
hypertension. They also assessed mono therapy versus dual therapy with regard to the 
various combinations of treatment in the various patient groups depending on risk 
factors. Treatment of hypertension needs to be individualised. Antihypertensives 
reduce cardiac output and/or peripheral resistance. Hypertension is associated with all 
forms of cardiovascular disease and peripheral arterial disease (PAD). The relative risk 
for developing PAD is noted to be less for hypertension than other risk factors such as 
diabetes or smoking (Norgren L. et al. 2007). The interaction between tissue 
oxygenation and antihypertensives is poorly studied.  
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The statistical analysis in Section 6.3 shows that there was no indicated difference 
noted between either the tcpO2 or ATP’s in those that were on statin therapy versus 
those not. 
This suggests, that in this study statins did not appear to affect oxygenation of the tissue 
or blood perfusion. Of note, if the standard p value of <0.05 was used, this may of 
suggested a difference between the groups.  
Statins are described as a lipid lowering drug and can be grouped into either low 
intensity, medium intensity or high intensity categories (NICE guidelines). 
The type of medication initially chosen to treat patients has also been the subject of 
many studies, with the NICE guidelines advocating all diabetics should be placed on 
statin therapy (National Institute for Health Care Excellence 2016a). There appears to 
be no one direct cause for hyperlipidaemia, so the treatment also must be multifaceted. 
 
There is evidence that treatment of hyperlipidaemia reduces both the progression of 
PAD and the incidence of claudication (Norgren L. et al. 2007). This directly impacts 
on disease progression which can lead to ulceration. Statins not only lower the risk of 
vascular events but they also improve the symptoms of PAD. (Coppola G. Novo S. 
2007). The Heart Protection Study (HPS) has published evidence that supports the 
routine use of statins in patients with PAD regardless of their cholesterol levels (Al 
Mahameed A. 2009, Heart Protection Study Collaborative Group 2002). It has also been 
suggested that cigarette smoking may enhance the effect of hypercholesterolemia. As 
is the case with antihypertensives the interaction between tissue oxygenation and statins 
is poorly studied. 
 
The statistical analysis in Section 6.3 shows that there was no indicted difference 
noted between either the tcpO2 or ATP’s in those that were diagnosed diabetic versus 
those not. 
 
In general all diabetic patients tend to be medicated tightly in a bid to reduce their 
long term complications, including arterial disease, renal failure, ocular complications 
and peripheral neuropathy. Many studies have shown an association between diabetes 
mellitus and the development of PAD. Claudication is approximately two times more 
61 
 
common in diabetic patients than in non-diabetic patients. In patients with diabetes, 
for every 1% increase in haemoglobin A1c there is a corresponding 26% increased 
risk of PAD (Norgren L. et al. 2007). PAD in patients with diabetes is more 
aggressive compared to the non-diabetics, and coupled with neuropathy this can lead 
to significant problems as mentioned earlier in chapter 2, section 2.1.  
 
Sixty six percent of tests in the study where diabetic with 74% of tests having an ulcer. 
The sample patients in this study is based primarily on those with ulcers and/or those 
referred to a vascular or a foot protection clinic. 
 
Can the majority of ulcers in these patients be considered neuropathic in origin (rather 
than vascular) and can this account for the absence of a difference between diabetics 
and non-diabetics in this study population? Is neuropathy the more dominant cause of 
ulceration in these diabetic patients rather than arterial disease? In addition to this, while 
the proportion of those with PAD is higher among diabetics than in the normal 
population, the non-diabetic group in this study presented due to the fact that there was 
a concern about their peripheral arterial supply (they presented with an ulcer). This will 
be further discussed in chapter 8.  
 
The outcome of this chapter would confirm smoking as the one single risk factor that 
has had a negative impact on both tests and hence effects both the macro and micro 
circulation. In patients who are smokers, the body’s ability to heal ulceration is 
diminished with regards to both blood perfusion and tissue oxygenation. Hypertension 
and hypercholesterolemia are closely linked to the severity of arterial disease and often 
medications used to treat them are commonly prescribed with a dual function eg: 
antihypertensives can also be used as a vasodilator to improve flow to extremities and 
not just or only for hypertension. The outcomes in this work are suggestive, that these 
medications have an effect on the macro circulation only, and seem to have spared the 
micro circulation.  
 
The tests in this audit have a large number of diabetics (66%) and a large cohort of 
ulcerations (74%), which have a burden of disease that we know will result in the 
prescribing of the aforementioned medications. International research has shown that 
these risk factors have a proven negative impact on ATP’s and TBI’s and the 
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prescribing of these drugs is performed in a bid to reduce this and its severity. This 
study has determined that diabetes or the use of antihypertensives and/or on statin 
therapy does not have a clearly defined impact on tcpO2 results, whereas they do have 
an impact on ATP’s. In a certain patient cohort both tests should be considered. tcpO2 
is a non invasive and cheap test, which can provide additional diagnostic information, 
that can perhaps be equally as valuable as a set of TBI’s in assessing perfusion and 
healing potential. It is also seen in this study that they are not affected by certain risk 
factors to the same extent as ATP’s and TBIs are.  
In the following chapter, further analysis was performed by directly comparing the 
results from the two tests against each other. This will aid in better determining the role 
of tcpO2.  
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Chapter 7 
 
 
 
 
Comparison of results between tcpO2 
and the TBI tests 
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Comparison of results between tcpO2 and the TBI tests 
 
7.1  Aim 
 
The aim of this chapter is to analyse initial results of TBI’s and tcpO2 examinations in 
all patients, and the relationship that exists directly between the two tests, if any. 
 
7.2  Method 
 
This study has looked at two different tests performed on a set of patients which have 
all presented to the vascular laboratory with foot ulceration. TBI’s looked at pressure 
as an indicator of arterial perfusion of a limb/toe and tcpO2 looked at tissue oxygenation 
at a particular site on the foot. In some cases, the non-ulcerated contralateral limb had 
both tests also recorded. Firstly a correlation coefficient was performed on the results 
from both tests in Microsoft excel 2013. Subsequently, the results from all the tests 
where plotted against each other using an X,Y scatter graph. This was also performed in 
Microsoft excel 2013. 
 
7.3  Results: 
 
Correlation coefficient: When the TBI’s and tcpO2 results were compared, the 
correlation coefficient was 0.49. When absolute toe pressures and tcpO2 results were 
compared the correlation coefficient was also 0.49.  
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Scatter Graph:  
 
 
 
Figure 7.1 TBI & tcpO2 scatter graph  
 
Graph details:  
The two axes were marked as follows;  
Centre horizontal axis: TBI’s, with the axis intersecting at 0.60 which is the value 
classed as a normal outcome for a TBI result (Cole, Norris and Walker. 2000).  
Centre vertical axis: tcpO2, with the axis intersecting at 40mmHg which is the marker 
above which spontaneous wound healing is likely in normal patients (Sheffield P.J. 
2004).  
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Plot area or quadrant A (Low TBI and Low tcpO2 group) are the results from both 
tests that were below the normal threshold i.e. the TBI was < 0.6 and tcp02 was < 
40mmHg. Results from the tests that fell into this quadrant were both below the normal 
values and classed as abnormal. 39% of all tests fall into this quadrant.  
 
Plot area or quadrant D (High TBI and High tcpO2 group) are the results from both 
tests that were above the normal threshold i.e. the TBI was > 0.6 and tcpO2 was > 
40mmHg. Results from the tests that fell into this quadrant were both above the normal 
values and classed as normal. 24% of all tests fall into this quadrant.  
 
Plot area or quadrant B (Low TBI and High tcpO2 group) are the results from both 
tests were the TBI result is low (<0.6) but the tcpO2 result is above the normal threshold 
(> 40mmHg). Results from the tests that fell into this quadrant have one test with 
normal values and the other with abnormal values. 31% of all tests fall into this 
quadrant.  
 
Plot area or quadrant C (High TBI and Low tcpO2 group) are the results from both 
tests were the TBI result is high (>0.6) but the tcpO2 result is below the normal threshold 
(< 40mmHg). Results from the tests that fell into this quadrant have one test with 
normal values and the other with abnormal values. 6% of all tests fall into this quadrant.  
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All four quadrants have been statistically compared to the overall population of results 
using a One Sample Proportion T-Test. A P-value less than 0.05 was considered 
significant. These tests were performed using Microsoft excel 2013. 
The results from these were as follows:  
 
A or Low TBI and Low tcpO2 group 
 There are significantly more tests with ulcers in the low TBI and low tcpO2 
group compared to overall tests (P-value 0.00073). A total of 87.5% of tests in 
this group have an ulcer compared to overall tests of 73.5% with ulcers. 
 There are significantly more tests with hypertension in the low TBI and low 
tcpO2 group compared to overall tests (P-value 0.0069). A total of 85.8% of tests 
in this group have hypertension compared to overall tests of 76.7% with 
hypertension. 
 Of note there was no statistically significant difference in the proportion of non-
smoker tests present in the low TBI and low tcpO2 group compared to the overall 
tests (P-value 0.078) but it was noted to be borderline. There were only 27.5% 
non-smokers in this group compared to the overall total of 34.8%.  
 
 
B or Low TBI and High tcpO2 group 
 There are significantly more tests on statin therapy in the low TBI and high 
tcpO2 group compared to overall tests (P-value 0.0452). A total of 77.3% of 
patients are taking statin therapy in this group compared with the overall total 
of 69.3%.  
 Of note there was no statistically significant difference in the proportion of ex-
smokers (P-value 0.0531) or non-smokers (P-value 0.0921) present in the low 
TBI and high tcpO2 group compared to the overall tests, but it was noted to be 
borderline. There were 49.5% ex-smokers in the group with overall total at 
40.3% and 27.8% of non-smokers in the group with the overall total at 34.8%. 
There were slightly less smokers in this group – actual 22.7% versus overall 
total of 24.8%.  
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C or High TBI and Low tcpO2 group 
 There were no statistically noted differences in any areas in this group.  
 Of note there was no statistically significant difference in the proportion of ulcer 
tests present in the high TBI and low tcpO2 group compared to the overall tests 
(P-value 0.083) but it was noted to be borderline. There were 80% ulcer tests in 
this group compared to the overall total of 73.5%.  
Overall it is important to note that the numbers in this groups are very small.  
 
 
D or High TBI and High tcpO2 group 
 There are significantly more tests who are non-smokers in the high TBI and 
high tcpO2 group compared to overall tests (P-value 0.0000006). A total of 
56.2% of tests in this group are non-smokers compared to overall tests of 34.8%. 
 There are significantly less tests who are ex-smokers in the high TBI and high 
tcpO2 group compared to overall tests (P-value 0.000014). A total of 24.7% of 
tests in this group are ex-smokers compared to overall tests of 40.3%.  
 There are significantly less tests who have ulcers in the high TBI and high tcpO2 
group compared to overall tests (P-value 0.00000022). A total of 53.4% of tests 
in this group have ulcers when compared to overall tests of 73.5%.  
 There are significantly less tests who have hypertension in the high TBI and 
high tcpO2 group compared to overall tests (P-value 0.00000044). A total of 
57.5% of tests in this group are medicating for hypertension compared to overall 
tests of 76.73%.  
 There are significantly less tests who are on statin therapy in the high TBI and 
high tcpO2 group compared to overall tests (P-value 0.012). A total of 57.5% of 
tests in this group are medicating with statins compared to overall tests of 
69.3%.  
 There are significantly more tests who are female in the high TBI and high tcpO2 
group compared to overall tests (P-value 0.0413). A total of 43.8% of tests in 
this group are female compared to overall tests of 34.2%. 
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7.4  Discussion 
 
Correlation Coefficient  
A positive correlation is when the correlation coefficient is greater than 0 with a +1 
signifying a perfect positive relationship. This simply means that both variables move 
in the same direction. It indicates a direct relationship, which means, that as one variable 
increases the other variable also increases. 
Likewise, a 0 indicates no correlation, with a -1 indicating a perfect negative 
correlation.  
 
The correlation coefficient between the tcpO2 and TBI tests was 0.49. While this is not 
a perfect correlation it is indeed a positive one. When using either the TBI index or the 
ATP, both correlation coefficients equated to 0.49. This suggested there was no 
difference in diagnosis related to the type of perfusion measurement used, TBI or ATP.  
 
Of interest and as stated earlier these tests measure two different functions and can be 
concluded to perhaps offer different degrees of diagnostic information to the clinician. 
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Scatter graph:  
 
This diagram, table 7.2, is a summary as per quadrant of the statistical analysis 
outcomes detailed in the results section of this chapter.  
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Figure 7.2 Summary of statistical analysis per quadrant  
 
Quadrant A (low TBI and low tcpO2 group) and D (high TBI and high tcpO2 group) 
account for a combined total of 63% of all test results. Both test results in each quadrant 
have the same outcome i.e. both with a normal result or both with an abnormal result. 
One test offers no different information to the other. These are classed as concordant 
tests.  
 
Quadrant B (low TBI and high tcpO2 group) and C (high TBI and low tcpO2 group) 
account for a combined total of 37% of test results and have two different results i.e. 
opposite outcomes. One test result is normal and the other abnormal. These are classed 
as discordant tests and are of most interest because of their discordance. Quadrant B 
(low TBI and high tcpO2 group) accounts for 31% of tests while quadrant C (high TBI 
and low tcpO2 group) represents only 6% of all tests.  
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To assist in the discussion of graph analysis, each of the quadrants are detailed in the 
table below showing the actual percentage of tests in each quadrant and the breakdown 
of the associated risk factors. The overall percentage outcomes for the entire test group 
are also shown in table 7.2 for means of comparison.  
 
     
  A (LL) B (LH) C (HL) D (HH)    
Male 71 68 60 56  Male 66 
Female 29 32 40 44  Female 34 
Smokers 30 23 25 19  Smokers 25 
Ex-Smokers 42 49 40 25  Ex-Smokers 40 
Non-Smokers 28 28 35 56  Non-Smokers 35 
Ulcers  88 70 80 53  Ulcers  74 
Non-Ulcers 12 30 20 47  Non-Ulcers 26 
HTN 86 82 70 58  HTN 77 
No HTN 14 18 30 42  No HTN 23 
On Statin  71 77 65 58  On statin 69 
Not on statin 29 23 35 42  Not on statin 31 
DM  68 70 65 56  DM  66 
No DM 32 30 35 44  No DM 34 
T1 17 22 8 15  T1 18 
T2 83 78 92 85  T2 82 
TBI 0.21 0.34 0.78 0.81    
tcpO2 20 53 29 56    
 
Table 7.1 Actual % outcomes per group Table 7.2 Overall results 
population % outcomes 
 
Graph analysis will be divided into two groups, a concordant group where the tests 
results have the same outcome and a discordant group where the tests have opposite 
results.  
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7.4.1  Concordant tests 
 
Low TBI & Low tcpO2 group (A) – (120 tests or 106 patients - 14 had bilateral tests)    
Statistical analysis has shown a significantly higher number of ulcerations in this group. 
Of all tests in the study where both outcomes are abnormal (i.e. this group), 88% of 
them presented with ulceration. An abnormal result was diagnosed when the TBI result 
was less than 0.6 and a tcpO2 value was less than 40mmHg. Patients have a higher risk 
of developing ulceration with both a low TBI and low tcpO2.  This often results in the 
healing of an ulceration being very difficult as both the perfusion and oxygenation of 
the tissue are compromised. In this case spontaneous healing is difficult and 
intervention is often required. In this group there were a total of 66 interventions on 61 
patients. When broken down there were 38 angioplasty procedures (on 33 patients - 3 
patients had bilateral angioplasty’s with 2 having 2 redo’s), 27 bypass procedures (on 
25 patients - 2 patients had bilateral grafts) and 1 common femoral endarterectomy. 
Amputations can often be a likely final outcome. Within this group there were 48 toe 
amputation procedures (on 46 patients – 2 patients had 2 toes amputated), 20 TMA’s 
(transmetarsal amputations - on 20 patients) with 13 of these having had a preceding 
toe amputation. There were 12 BKA’s (below knee amputation on 12 patients) with 6 
having a previous TMA and 4 a previous toe amputation. There was 5 AKA’s (above 
knee amputation on 5 patients) with one having a previous TMA and 2 having previous 
toe amputations. These are a difficult cohort to manage and often have a very complex 
medical history.  
 
Statistical analysis has also shown a significantly higher rate of tests medicating for 
hypertension in this low TBI and low tcpO2 group which is probably likely due to 
individual medical history and overall risk of disease.  
 
High TBI & High tcpO2 group (D) (73 tests or 55 patients -18 had bilateral tests)    
Conversely to group A, statistical analysis has shown a significantly lower number of 
ulcerations in this group. Of all tests in the study where both outcomes are normal (i.e. 
this group) only 53% of them had an ulceration. Both perfusion and oxygenation of 
tissue is above normal standards in these tests hence reducing the risk of ulceration. 
Even though ulceration is present despite normal test results, there are other reasons 
why patients develop ulcers (discussed in chapter 2) such as venous disease, 
73 
 
neuropathy, infection of a wound and foot deformities. With both tests having normal 
results these patients are more likely to heal their ulcers without interventions and less 
likely to require amputation. In this group there were no revascularisation interventions. 
There were 4 amputations, with 2 (2 patients) toe amputation procedures due to 
osteomyelitis and 1 TMA also due to the same reason. There was 1 BKA due to a 
Charcot foot with an associated non-healing ulcer in the presence of adequate perfusion. 
Of note osteomyelitis is an infection which is treated firstly with antibiotics and if this 
fails requires amputation of the infected area 
 
Statistical analysis did show less tests who were ex-smokers in this group but it also 
showed significantly more tests who were non-smokers. We know smoking affects 
peripheral circulation and has a damaging effect on both the arteries and tissue 
oxygenation, so it is understandable this group has been subjected to less of the damage 
smoking causes. There were 56% of tests classed as non-smokers in high TBI and high 
tcpO2 group versus 28% in the low TBI and low tcpO2 group, 28% in the Low TBI and 
high tcpO2 group and 35% in the high TBI and low tcpO2 group. 
Statistical analysis has also shown a significantly lower rate of tests medicating for 
hypertension and on statin therapy in this high TBI and high tcpO2 group, which is 
probably likely due to medical history and their overall risk of disease as was seen in 
the low TBI and low tcpO2 group.  
 
Of note and which was not deemed statistically significant it can be seen that there were 
less diabetics in the high TBI and high tcpO2 group than in the low TBI and low tcpO2 
group, and indeed any other group. There were 56% of test diabetics in the high TBI 
and high tcpO2 group versus 68% in the low TBI and low tcpO2 group, 70% in the low 
TBI and high tcpO2 group and 65% in the high TBI and low tcpO2 group.  
 
In these groups both tests have similar outcomes and provide no additional information 
to aid in the treatment of patients. Perhaps if anything with tests that are just borderline 
normal or abnormal, perhaps if the other test result is not borderline it may encourage 
further diagnostic investigation.  
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7.4.2  Discordant tests 
 
High TBI & Low tcpO2 group (C) (20 tests or 20 patients)    
In comparison to other groups, the statistical analysis of the tests in this group has 
shown no significant differences with regards risk factors or ulcer numbers.  
 
Group C with a high TBI and a low tcpO2 result accounts for just 6% of the tests in the 
study. When this group was further analysed the average TBI was 0.78 with an average 
ATP of 126mmHg. The average tcpO2 baseline was 29 mmHg which increased to 58 
post 10 minutes O2 as per the protocol described in chapter 5.3.1. There were noted to 
be no interventions in this group. 
 
There are two points to be considered here: 
1) falsely elevated digital pressures due to calcification. Digital arteries can become 
incompressible due to medial sclerosis or calcification. Within this group there were 6 
tests which had a digital x-ray and were reported as having vascular calcification, but 
the overall number of patients with digital x-rays is inadequate to be quantified and to 
draw any conclusion. Further research in this area is required.  
2) falsely depressed tcpO2 must also be considered. This can be attributed to a number 
of factors including soft tissue infection, oedema, venous hypertension, steroids, other 
immunosuppressants or inadequate nutrition (Fife et al. 2009). 
Of note there were 6 patients who had osteomyelitis with 5 of these requiring a toe or 
toes to be amputated and one resulting in a BKA. Although the baseline is low the 
response to the inhaled 100% O2 was good, which suggests that perhaps many of these 
patients are not as ischaemic as their baseline values might suggest. Further study in 
this area should be considered. Perhaps a centrally placed truncal sensor measurement 
would be helpful in further investigating this.  
 
Low TBI & High tcpO2 group (B) (97 tests or 82 patients – 15 had bilateral tests)    
This discordant group with its low TBI and high tcpO2 results account for 31% of all 
tests in the study.   
When statistical analysis was carried out on this group, the number of tests on statin 
therapy (77%), was significantly statistically higher than in comparison to the other 
groups and also higher than the overall number of tests (69%). It was shown in chapter 
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3, section 6.3.3 that there is a significant difference in ATP in those on statin therapy 
versus those not, with there being no difference in tcpO2 results between those on statins 
versus those not. ATP’s are lower in the test group on statin therapy. Although not 
significantly relevant it was noted that the number of tests medicating for hypertension 
in this group was also 5% higher than the overall number of tests. It was also shown in 
chapter 3, section 6.3.2 that there is a significant difference in ATP’s in those on 
antihypertensives versus those not. Likewise, those on antihypertensives had reduced 
ATP’s. This finding concurs with the groups with low TBI’s, which have large numbers 
of tests medicating for either hypertension and/or taking a statin and vice versa in the 
groups where the TBI’s are normal, the number of tests medicating for hypertension 
and/or taking a statin are reduced.  
 
The number of ulcers in this group stands at 70% giving it a lower number of actual 
ulcers by 4% than the overall number of ulcers. The number of diabetics in this group 
also stands at 70% which is 4% higher than the overall number (22% of these diagnosed 
as Type 1 which is 4% higher than the overall number). In general all diabetic patients 
tend to be medicated tightly in a bid to reduce the negative impacts it can have on the 
body.  
 
The average TBI result in this group was 0.34 with 0.6 considered a normal outcome. 
There were 11 (97 in total in the group) tests that were borderline abnormal, with the 
results between 0.6 and 0.55. Fifty two tests were above the average TBI of 0.34, with 
45 below the average of 0.34.  
The average ATP was 55mmHg with the average tcpO2 at 53mmHg.  
There were 11 interventions in total which divided into 6 angioplasty’s on 6 patients 
and 5 bypass grafts on 5 patients.   
 
There were 21 toe amputations on 21 patients. There were 7 TMA’s with one patient 
having bilateral TMA’s. Within these 6 TMA patients, 4 had a previous toe amputation. 
There were 6 BKA’s on 6 patients with 4 AKA’s on 4 patients (one of these being a 
revised BKA due to infection).  
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Flow chart 7.1 shows the numbers of tests with a TBI < 0.6, which is divided into two 
groups - tcpO2 < 40 and tcpO2 > 40.  These are subdivided into interventions and 
amputations.  
 
 
 
 
 
Flow chart 7: Tests with a TBI < 0.6  
 
 
 
In summary the numbers in group B (low TBI and high tcpO2) regarding interventions 
and amputations are relatively large in comparison with the other groups C & D. (See 
table 7.3 below)  
 
Group  
A 
(LL) 
B 
(LH) 
C 
(HL) 
D 
(HH) 
Overall test numbers 120 97 20 73 
Interventions 66 11 0 0 
Toe/s amputated 48 21 5 2 
TMA's 20 7 0 1 
 BKA's 12 6 1 1 
 AKA's 5 4 0 0 
 
Table 7.3 Intervention/amputation numbers of tests across all the groups  
 
This table 7.3, looks at numbers of tests with regards to interventions and amputations. 
In some cases one or more interventions or amputations can be attributed to one patient; 
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for example a patient may have had an angioplasty or bypass graft and gone on to lose 
one toe or more which may have then ended in a TMA or BKA.  
 
Groups C (High TBI & low tcpO2) & D (High TBI & high tcpO2) fair best with no 
interventions and small numbers of amputations, although the overall number of tests 
in group C are quite low. 
Group A, which has low results in both tests, has the largest numbers of both 
interventions and amputations and also the largest number of actual tests in the study.  
Group B which also has a low TBI result, but, has a high tcpO2 result, is noted to be the 
second largest group in the study. This group has a very obvious lower number of 
interventions and amputations.  
 
In conclusion the low TBI and high tcpO2 or group B is of particular interest because 
of its discordant tests and of the numbers of tests that fall into it. It suggests that in this 
patient cohort both tests are important in their own right. This group although it has a 
significant incidence of arterial disease and has required a number of interventions, the 
proportions of these are significantly lower when compared to the low TBI low tcpO2 
group. This would indicate that even in the presence of proven arterial disease i.e. 
reduced TBI’s, that if the tcpO2 result is > 40mmHg that intervention does not need to 
be the first treatment choice. Traditionally in the setting of ulceration with critical 
ischaemia, reconstructive surgery or even amputation has been required. Now with the 
emergence of tcpO2 and with its evolving recognition as a valuable diagnostic tool, 
perhaps a “wait and see” approach can be taken. This low cost test can lead to a 
reduction in the need for expensive imaging tests and even some primary interventions, 
resulting in an overall reduction in the financial burden of this cohort on an acute 
primary care facility. This study has proven that tcpO2 is a valuable and complimentary 
test to the traditional TBI’s in ulcerated patients. Of note, more importantly, in a setting 
were TBI’s can’t be performed due to amputation or ulceration of the hallux, tcpO2 
should be considered as the alternative first choice test.  
 
The next chapter focuses specifically on the ulcer patients and details the outcomes in 
relation to these test results.  
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Chapter 8 
 
 
 
 
Examination of factors affecting ulcer 
outcomes 
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Examination of factors affecting ulcer outcomes 
 
 
8.1  Aim 
As this tcpO2 test was introduced to explore the diagnostic options for patients attending 
the diabetic foot protection clinic, further analysis of data focused on all tests performed 
on patients who had an active foot ulceration and more specifically those who were 
diagnosed as diabetic.  
 
8.2  Method 
Statistical analysis of all tests in the 3 year period was undertaken and included 
student’s t tests which was used to determine if two sets of data are significantly 
different from each other. The tests were evaluated at a 95% significance level (p-value 
< 0.05). These tests were performed using Microsoft excel 2013. Further analysis of 
data in the chapter used the Fishers exact test. This tests is used to examine the 
significance of the association (contingency) between the two kinds of classification of 
data and is more appropriate when sample sizes are small.  
 
8.3  Results 
There were 310 tests analysed in which 228 were performed on ulcerated limbs and 82 
on limbs without ulceration. The tests labelled as non ulcerated tests were taken from 
patients who had an ulcer on the contralateral limb.  
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Figure 8.1 below, shows the breakdown of the risk factors in the ulcer versus the non-
ulcer groups. There were more smokers in the ulcer group, 27% versus 19% in the non-
ulcer group. There were 83% of the ulcer group medicating for hypertension versus 
62% in the non-ulcer group. There were 72% of the ulcer group on statin therapy versus 
64% in the non-ulcer group. Finally there were 74% of the ulcer group that were 
diabetic versus 42% in the non-ulcer group.  
 
 
Percentage risk factors in the ulcer versus the non-ulcer test groups  
 
 
Figure 8.1 Comparisons of risk factors in the ulcer V’s non-ulcer tests 
 
 
 
 
 
  
0
10
20
30
40
50
60
70
80
90
100
Smokers Hypertensive Statin therapy Diabetic
Non Ulcers
Ulcers
81 
 
8.3.1 Analysis of tcpO2 and ATP’s in the ulcer and non-ulcer patients  
The following chart shows the results when the two tests were compared in patients 
with an ulcer present versus those with no ulcer.  
Test tcpO2(mmHg)  ATP (mmHg) 
Ulcer 37 63 
No ulcer  47 81 
P-Value p = 0.00014 p = 0.005 
Outcome Indicated difference Indicated difference 
 
Table 8.1 tcpO2 and ATP’s in the ulcer and non-ulceration group 
 
Mean (± SD) tcpO2 between tests with ulceration and those with no ulceration were as 
follows: 
Those with ulceration 37 ± 20 mmHg and those with no ulceration 47 ± 17 mmHg.  
There was an indicated difference (p = 0.00014) between the mean tcpO2 in the tests 
with ulceration and those without.  
 
Mean (± SD) absolute toe pressures between tests with ulceration and those with no 
ulceration were as follows: 
Those with ulceration 63 ± 49 mmHg and those with no ulceration 81 ± 47 mmHg.  
There was an indicated difference (p = 0.005) between the mean absolute toe pressures 
in the tests with ulceration and those without. 
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8.3.2 Analysis of patients with ulceration – Diabetic V’s non-diabetic patients and 
if tcpO2 is significant  
 
Of the total 228 ulcer tests, 170 (75%) of these were diabetics. There were 82% of these 
diagnosed as Type 2 and 18% as Type 1. The non-diabetic group were patients who 
were classified as not having diabetes at the time of presentation. 
 
Test tcpO2(mmHg)  ATP (mmHg) 
Diabetic 39 66 
Non diabetic 32 55 
P-Value p = 0.04 p = 0.16 
Outcome Indicated difference No indicated difference 
 
Table 8.2 tcpO2 and ATP’s in tests with ulceration in both the diabetic and non-
diabetic group.  
 
Mean (± SD) tcpO2 in ulcer tests that were diabetic and those that were not were as 
follows: 
Ulcer tests in the diabetic group 39 ± 20 mmHg and those ulcers that were not diabetic 
32 ± 19 mmHg.  
There was an indicated difference (p = 0.04) in the mean tcpO2 between the diabetic 
and non-diabetic patient tests in the ulcer group. 
 
Mean (± SD) absolute toe pressures in ulcer tests that were diabetic and those that were 
not were as follows: 
Ulcer tests on those that were diabetic 66 ± 49 mmHg and those ulcers that were not 
diabetic 55 ± 49 mmHg.  
There was no indicated difference (p = 0.16) between the mean absolute toe pressures 
in the ulcer group between the diabetic and non-diabetic patient. 
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8.3.3 Analysis of diabetic tests with ulceration – Type 1 V’s Type 2 tests  
 
Test tcpO2(mmHg)  ATP (mmHg) 
Type 1 40 61 
Type 2 38 67 
P-Value p = 0.84 p = 0.39 
Outcome No indicated difference No indicated difference 
 
Table 8.3 tcpO2 and ATP’s in the type 1 versus type 2 diabetics 
 
Mean (± SD) tcpO2 in ulcer tests who were Type 1 diabetic and those who were Type 
2 diabetic were as follows: 
tcpO2 on ulcer tests with Type 1 diabetics 40 ± 19 mmHg and those ulcers who were 
Type 2 diabetic 38 ± 21 mmHg.  
There was no indicated difference (p = 0.84) between the mean tcpO2 in the ulcer Type 
1 diabetic and ulcer Type 2 diabetic patient tests. 
 
 
Mean (± SD) absolute toe pressures in ulcer tests who were Type 1 diabetic and those 
who were Type 2 diabetic were as follows: 
Absolute toe pressures on ulcer tests with Type 1 diabetes 61 ± 48 mmHg and those 
ulcers who were Type 2 diabetic 67 ± 49 mmHg.  
There was no indicated difference (p = 0.39) between the mean absolute toe pressures 
in the ulcer Type 1 diabetic and ulcer Type 2 diabetic patient tests.   
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8.4  Ulceration outcomes 
The final analysis was focused on the smaller subgroup of patients with diabetes and 
active foot ulceration in an attempt to identify the potential utility of tcpO2 in (1) 
determining the likelihood that an ulcer will heal without the need for revascularisation; 
(2) in identifying those patients who are likely to require operative revascularisation 
and (3) identifying the success or otherwise of a vascular intervention in altering tissue 
oxygenation levels. The flow chart below details the breakdown of test numbers.  
 
 
 
 
Flow Chart 8: Breakdown of tests 
 
The total patient population of 170 with diabetes and foot ulceration were followed in 
the clinic during the period of the study. The outcome of each ulcer at the conclusion 
of the study was categorised into two groups as below:  
1) those who had no revascularisation interventions such as an angioplasty, 
endarterectomy or bypass procedures  
2) those who had some form of intervention carried out.  
 
Each of the groups were further broken down into two distinct categories. These 
categories were determined as per a review of the patients chart post an outpatient 
appointment during treatment or follow up of their ulceration. These were as follows:   
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 Healed – skin closed over and ulcer completely healed 
 Non – healed – no significant improvement noted in ulcer size/area and ongoing 
ulcer dressings required +/- a vascular intervention. For the purposes of 
analysis, these were treated as non-healed as the final outcome could not be 
determined.   
 
The following two sub-sections will analyse the tests separately with regards those 
which had an intervention and those which didn’t.  
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8.4.1 Non intervention tests 
Of the 170 diabetic ulcer tests, 124 had no interventions within the time line of the study 
and these were evaluated and monitored until the end of the treatment period with 
regards to their treatment/outcome.  
Two analyses were performed comparing the healing/non-healing groups using tcpO2 
and absolute toe pressures (ATP’s). Based on the literature, a cut off of 30mmHg was 
used for ATP’s and 40mmHg for tcpO2. Using Fishers exact test (which is better for 
small numbers) the following tables illustrates the tcpO2 and ATP baselines in the 
patient cohort with diabetic foot ulcers (DFU).The tests were evaluated at a 95% 
significance level (p-value < 0.05).  
 
Table 8.4 below compares absolute toe pressures to healed / non healed outcomes using 
a threshold of 30mmHg.  
ATP's >30 <30 TOTAL 
HEALED 73 12 85 
NON HEALED 34 5 39 
      124 
 
Table 8.4 Analysis of ATP’s: Healed V’s Non healed outcomes  
 
 
Figure 8.2 Comparisons of ATP’s: Healed V Non healed outcomes  
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A Fishers exact test was performed to compare expected outcome and actual outcome 
in this test group. There was no significant difference (p = 0.84) in the ATP threshold 
of 30mmHg to indicate healed / non healed outcomes.  
 
 
Table 8.5 below compares the tcpO2 values to healed / non healed outcomes using a 
threshold of 40mmHg.  
TCPO2 >40 <40 TOTAL 
HEALED 53 32 85 
NON HEALED 18 21 39 
      124 
 
Table 8.5 Analysis of tcpO2: Healed V’s Non healed outcomes  
 
 
Figure 8.3 Comparisons of tcpO2: Healed V Non healed outcomes  
 
A Fishers exact test was performed to compare expected outcome and actual outcome 
in this test group. There was no significant difference (p = 0.11) in the tcpO2 threshold 
of 40mmHg to indicate healed / non healed outcomes 
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It was decided to investigate if using a different tcpO2 cut off value to the literature 
(40mmHg) would provide more diagnostic discrimination.  The tcpO2 test results 
were analysed at 35mmHg, 30mmHg, 25mmHg and 20mmHg with the threshold 
value of 30mmHg being the only value to be significantly statistically different.   
 
Table 8.6 below compares tcpO2 to healed / non healed outcomes 
TCPO2 >30 <30 TOTAL  
HEALED 69 16 85 
NON HEALED 25 14 39 
      124 
 
Table 8.6 Analysis of tcpO2: Healed V’s Non healed outcomes  
 
 
Figure 8.4 Comparisons of tcpO2: Healed V Non healed outcomes  
 
A Fishers exact test was performed to compare expected outcome and actual outcome 
in this test group. There was a significant difference (p = 0.04) in the tcpO2 threshold 
of 30mmHg to indicate healed / non healed outcomes. 
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In further evaluating the significance of the reduction in tcpO2 to 30mmHg, and to aid 
in the predication of outcomes, the sensitivity / specificity of the two tests were 
analysed. A tcpO2 threshold of 30mmHg was used with an ATP threshold of 30mmHg 
also used.  
The following table 8.7 details the breakdown of the tests for this analysis.  
 
 Non Healed 
Disease present 
(Ischaemia) 
Healed 
Disease absent 
(No Ischaemia) 
tcpO2        <30 
Positive test 
14 (a) 16 (c) 
>30 
Negative test 
25 (b) 69 (d)  
ATP           < 30 
Positive test 
5 (a) 12 (c) 
>30 
Negative test 
34 (b) 73 (d)  
 
Table 8.7 Analyses of healed Vs non healed test numbers  
 
For the purposes of analysis, a test was deemed to be "positive" if the pressure was < 
30mmHg i.e. low pressure = ischaemia = expected non-healing. A test was deemed to 
be “negative” if the pressures was >30mmHg i.e. high pressure = not ischaemic = 
expected healing. 
 
Test Positive Predictive Value 
(PPV) 
a 
a + c 
Negative Predictive Value 
(NPV) 
d 
b + d 
tcpO2  46.67% 73.40% 
 
ATP  29.41% 68.22% 
 
 
Table 8.8 Predictive values table (For a, b, c & d values refer to table 8.7 above) 
Based on the breakdown of test numbers (124 diabetic ulcer tests), a test showing a 
tcpO2 of greater than 30mmHg was deemed a "negative test" for ischaemia and 
indicated a 73% chance that the ulcer will heal (NPV). Conversely, a value of less than 
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30mmHg (a "positive test" for ischaemia indicated a 46% chance that the ulcer will fail 
to heal (NPV).  
 
Likewise with the ATP tests, a test greater than 30mmHg was deemed a “negative test” 
and less that 30mmHg was deemed a “positive test”. Both the negative (68%) and 
positive (29%) predictive values are lower in the ATP’s when compared to tcpO2.  
The analysis of the data from Table 8.6 shows that a tcpO2 level of 30mmHg is 
statistically significantly associated with subsequent healing/non-healing of ulcers (p = 
0.04). A tcpO2 of <30mmHg is associated with ulcer non-healing in 46% of cases. From 
this data tcpO2 was a more accurate indicator of healing rather than ATP’s, which had 
a non-healing predictive value of 29%.  
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8.4.2 Intervention tests 
A large majority of diabetic foot ulcers are superficial and related primarily to 
neuropathy. These are managed by offloading and often do not require any vascular 
intervention. 
Those that are ischaemic or neuroischaemic who may benefit from intervention were 
identified by clinical assessment (depth of ulcer, measures of osteomyelitis, pain, extent 
of tissue loss, healing response to offloading), measures of perfusion (tcpO2, TBI), 
consideration of comorbidities and fitness for surgery, previous surgical history and 
known extent of vascular disease, anatomy of disease based on duplex, CT or 
angiogram, and patient preference. 
There was no one factor that decided intervention. The decision may also have be 
revised/changed over time where, for example, the ulcer failed to respond or got deeper 
or more extensive despite therapy.  
The group of non-healing patients who had an intervention (46) performed were 
analysed. These patients were subsequently followed to determine whether their ulcer 
had healed at the conclusion of the observation period. This cohort had pre and post test 
data collected using both modalities. Unfortunately a number of patients were excluded 
from the data analysis (23) due to a number of reasons – they had been discharged and 
not seen prior to leaving the hospital or before the end date of the study and/or they had 
a hallux or TMA amputation at the time of intervention meaning a post procedure 
TBI/ATP was not possible and they only had a tcpO2 test performed.  
 
The following table looks at the outcomes of the diabetic tests (23 tests) which had a 
revascularisation procedure in a bid to aid healing or prevent amputation.  
 
  HEALED (12) NON HEALED (11) 
  Pre Post Pre Post 
tcpO2 29 37 23 20 
ATP 24 36 21 22 
TBI 0.17 0.27 0.13 0.15 
 
Table 8.9 Average measurements of diabetic ulceration pre and post intervention  
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Of the healed ulcers post intervention (12) there was an increase in both test results in 
comparison to the non healed interventions. Unfortunately for this study the numbers 
were deemed too small for any significant analysis to be performed.  
 
The amputations levels where noted to be significant in this group in comparison to the 
non intervention group. The table below 8.10 details the number in each group.  
 
  
Non Intervention group 
                     (124) 
Intervention group 
                 (23) 
AKA 2 2 
BKA 9 3 
TMA 20 5 
Toe  41 16 
Total 72 26 
 
Table 8.10 Amputation numbers   
  
The percentage of proximal or major amputations in the non intervention group versus 
the intervention group are 15% and 19% respectively. Of note in the non intervention 
group 3 or 27% of these AKA/BKA’s were due to Charcot foot.  
There was a larger incidence of distal or minor amputations in the intervention group 
with some having more than one amputation procedure during the treatment period.     
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8.5  Discussion 
 
As in previous chapters it is known that smoking has a negative effect on the body, and 
affects both the micro and macro circulation, with a significant reduction shown in 
tcpO2 and in the TBI test results in smokers. In the ulcer test group 27% of tests were 
noted to be smokers. Cessation is extremely important in the ulcer patients. 
Student t tests carried out earlier in the chapter on all tests, show that the mean tcpO2 
and ATP’s are significantly lower in those with ulceration versus those with no ulcers. 
This is understandable as ulceration may result from reduced perfusion and/or 
oxygenation to a limb resulting in abnormal test results. Ulceration is a multifactorial 
process with nutrient supply to the ulcerated area a key component which can be 
measured by either or both the microcirculation (Via ATP’s) and the micro circulation 
(Via tcpO2).  
Further analysis in the chapter focused specifically on the ulcer test group only (section 
8.3.2), and on the diabetic tests versus the non-diabetic tests – 75% of ulcers were 
diabetics. There was an indicated difference in the tcpO2 in the diabetics versus the non-
diabetics. There was no indicated difference in the ATP’s in the diabetics versus the 
non-diabetics. Can it be suggested that tcpO2 in the ulcerated diabetics offers alternative 
information? It is evident that although PAD is present in both the ulcerated diabetic 
and non-diabetic groups with no statistical difference noted between them, diabetic 
ulcers have better micro circulation that non diabetic ulcers. These results suggest that 
in the non-diabetic group the ulcers are the result of ischaemia due to their low TBI/ATP 
and tcpO2 results, while in the diabetic group there are a greater proportion of 
neuropathic ulcers due to their higher TBI/ATP and tcpO2 results. In patients with 
diabetes, the presence of neuropathy is also an important risk factor for the development 
of ulceration. Neuropathy can and frequently does occur without the presence of 
significant ischaemia. In the overall ulcer population – especially among the subset with 
diabetes - there may be a substantial number of patients with ulceration whose perfusion 
is normal or near normal. These results have shown that tcpO2 can help identify patients 
with adequate perfusion in the presence of ulceration and therefore tcpO2 is a valid 
alternative test in the absence of being able to perform a TBI/ATP in the diabetic 
patient.  
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Further statistical analyses focused on the diabetic ulcerations due to the large 
proportion of these in the study cohort (124). The main concern with ulceration is 
healing, how long it will take, if it will occur and if any interventions will be required. 
With regards to tcpO2 measurements and the predication of wound healing outcomes, 
the consensus in published literature suggests that cut off values above 40mmHg are 
required for adequate wound healing and that those below 40mmHg have uncertain 
healing outcomes with a large majority of wounds failing to heal (Sheffield P.J. 2004, 
Yang C. et al. 2013). Analysis using 40mmHg in this study showed no significant 
difference in healing / non healing outcomes however other values were explored.  
This body of work would suggest that tcpO2 with a threshold of 30mmHg is the best 
predictor of wound non-healing in this patient cohort. Statistical analysis has shown 
that there was a significant difference (p = 0.04) in tcpO2 using the 30mmHg threshold 
with regards to healing / non healing outcomes. ATP’s at 30mmHg and tcpO2 at 
40mmHg when analysed showed no significant difference in healing outcomes. Further 
evaluation of the 30mmHg threshold for tcpO2 showed that tcpO2 is more specific and 
sensitive in predicating wound healing versus ATP’s (see figure 8.8 ).  
  
There were 23 tests who had pre and post intervention tests for analysis, but for this 
study the numbers were too small for any significant statistical analysis purposes.  
 
In summary this piece of work has illustrated that tcpO2 can assist the treating physician 
in the prediction of wound healing and provides valuable information in the ulcerated 
patients. Importantly, the use of tcpO2 (even in the presence of PAD) allows for the 
identification of a group of patients with adequate skin perfusion but with an active 
ulcer, suggesting the presence of an alternative cause. This additional information 
provides the attending medical professional with more options in the treatment of these 
ulcers i.e. in the presence of PAD, these patients ulcers may heal without 
revascularisation intervention. This information is unavailable in the absence of tcpO2. 
 
The tcpO2 test has proven itself as a complimentary and valuable diagnostic test to a 
TBI / ATP. Given the complexity of many of the diabetic patients presenting to vascular 
clinics in recent times, it has become more difficult to treat ulceration successfully. This 
is a complex patient group, many of which are well known to the service. Amputations 
can be high in this cohort and in the absence of a hallux to record a TBI/ATP it is 
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essential to be able to rely on another testing modality to assess perfusion or ability to 
heal wounds. tcpO2 has had a positive impact on their treatment and has proven to be a 
very beneficial test.  
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9.0  Conclusion and Recommendations 
 
Ulcers are very problematic for both the patient and healthcare provider with there 
being no one universally accepted test that can predict wound healing. The aim of this 
thesis was to audit results of a new test, (tcpO2), that was introduced into the vascular 
laboratory service over a three year period.  
 
Chapter 6 compared the risk factors of smoking, diabetes, hypertentsion and the use of 
statin therapy on the results of the two tests, TBI’s and the newly introduced tcpO2. The 
results from both tests were significantly reduced in smokers, with ATP’s only reduced 
in those medicating for hypertension. This audit did not show any differences in the 
tcpO2 levels between those on medications (antihypertensive and statins) and those not. 
The interaction between tissue oxygenation and the use of antihypertensives and statin 
therapies are poorly studied and warrants further investigation.  
This study did confirm that smoking is the one single risk factor that has a negative 
impact on both tests and as such affects both the micro and macro circulation and those 
patients with ulceration should be very strongly advised against its use.  
 
Chapter 7 was a direct comparison between the results of both tests. A correlation 
coefficient of 0.49 was achieved, and although not a perfect correlation it is a positive 
one. Analysis of the data highlighted one cohort of most interest. This group (31% of 
total tests) contained the tests where the TBI’s were reduced or abnormal but where 
there was a normal tcpO2. i.e. > 40mmHg. When this group is compared to the other 
group with both an abnormal TBI and also an abnormal tcpO2, the number of 
interventions and amputations are significantly lower in the former i.e. the group with 
the normal tcpO2. This implies that having a normal tcpO2 in the setting of PAD will 
lead to a higher level of ulcer healing and a lower incidence of intervention and 
amputation. It is therefore valid in these patients to take a “wait and see” approach 
rather than perform further immediate diagnostic tests, admissions or interventions. 
tcpO2 is a valuable and complimentary test to the traditional TBI. Further investigation 
of this group is highly recommended and was outside the scope of this study.  
 
Chapter 8 examined diabetic ulcer healing outcomes. Of note there was a statistical 
difference in the tcpO2 tests only, between the diabetic and non diabetic patients. The 
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differing aetiology of ulceration in the diabetic and non-diabetic populations is an 
important consideration in the treatment of these patients. In the non-diabetes most 
ulcers are ischaemic and although some patients may have neuropathy, it is less 
common. In those with diabetes a significant number of ulcers are due to neuropathy, 
with little or no ischaemic component, so average perfusion values appear better as was 
seen in section 8.3.2. A comprehensive assessment of these patients including the 
evaluation of and documentation of their neurological status would be very informative, 
but in this instance was beyond the scope of the vascular laboratory assessments carried 
out and this data was not available for the purpose of this study.  
Finally further statistical analysis in the chapter focused on the healing outcomes of the 
diabetic ulcers. It can be suggested that a threshold level of 30mmHg is the best 
predictor of wound healing /non-healing in this patient cohort. Further evaluation of the 
30mmHg threshold for tcpO2 showed that tcpO2 is more specific and sensitive in 
predicating wound healing versus ATP’s.  
 
In conclusion this thesis has led to a number of observations:  
 Smoking is the single risk factor proven to effect both tcpO2 and ATP’s, and 
should be strongly advised against in all ulcer patients.  
 The use of tcpO2 and its comparison to TBI’s, has led to the identification a 
previously unknown group of patients, where the TBI result was reduced but 
the tcpO2 result was normal. This group had significantly less interventions and 
amputations. 
 Neuropathy is a significant factor when dealing with diabetic patients with 
ulceration, which vascular physiologists may not always be aware of the 
importance of.  
 A tcpO2 threshold level of 30mmHg is the best predictor of wound healing in 
this diabetic ulcer patient cohort. It can be suggested that tcpO2 is more specific 
and sensitive in predicating wound healing versus ATP’s 
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Recommendations following this thesis are as follows:  
 Further detailed analysis of the group with reduced TBI’s and a normal tcpO2 
test result is recommended.  
 Although it is widely recommended that a neurological lower limb assessment 
of diabetic ulcer patients on initial presentation should be performed, and that 
there should be widespread active multidisciplinary management programmes 
in place to focus on education, prevention and early intervention in the diabetic 
population, there is a variation in practice across Ireland. 
 tcpO2 is a valuable and complimentary test to the traditional TBI and should be 
a considered test in all patients who present with an ulcer. Given the complexity 
of the diabetic patient cohort tcpO2 is an important and beneficial test which 
should be performed when deciding on treatment. 
 Subsequent to the completion of this body of work and resulting indication of 
the usefulness of tcpO2 as a valuable test, the laboratory protocol has now 
evolved to include a simultaneous trunk tcpO2 measurement. This allows a 
systemic factor to be considered via the calculation of an RPI (Regional 
Perfusion Index). The ability of this RPI to better predict healing potential is 
currently being investigated in Tallaght University Hospital.  
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